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Abstract 
 
O-antigen, the most surface exposed moiety of bacterial lipopolysaccharide (LPS), plays 
several roles in pathogenicity. The biosynthesis of O-antigen starts by the formation of a 
phosphoanhydride bond linking a sugar phosphate with a membrane isoprenoid lipid 
phosphate. Two distinct families of integral membrane proteins catalyze this reaction. 
The protein WecA is the prototypic member of one of these families, termed the 
polyisoprenyl-phosphate N-acetylaminosugar-1-phosphate transferase (PNPT) family. 
Because the donor nucleotide sugar is only available in the cytosol, cytosolic exposed 
regions of WecA are expected to be critical for the catalytic activity of the enzyme. 
Therefore, elucidating an accurate topological map of WecA is essential to understand its 
function. While a topological model has been determined with some level of accuracy in 
certain regions of WecA, various protein-protein, protein-lipid, and protein-aqueous 
interfaces are not precisely mapped and we have also found inconsistencies between in 
silico prediction models and experimental data. We hypothesize that the borders between 
the transmembrane domains (TMs) and the cytosolic loops of WecA are critical for its 
function. In particular, this thesis focuses on cytoloops 1 and 4 (including the universally 
conserved VFMGD motif), and TMs IV and V (a putative interaction site for the lipid 
substrate). The locations of these border residues were identified by the topological 
accessibility of specific amino acids using the substituted cysteine accessibility method 
(SCAM) combined with PEGylation. This approach offers several advantages over other 
classical SCAM methods, especially by avoiding the need to purify the labeled protein 
after sulfhydryl chemistry. PEGylation involves the covalent mass labeling of accessible 
sulfhydryl groups with the large thiol reagent methoxy-polyethylene glycol-maleimide 
(PEG-Mal, 5 kDa), and detection using a gel shift assay. Orientation is differentiated by 
treatment of EDTA-permeablized cells compared to treatment in membrane preparations. 
This thesis describes the adaptation and use of PEGylation for the topological analysis of 
WecA. The results provide further refinement of the WecA topological map, and the 
method can be extended to other integral membrane proteins involved in O-antigen 
assembly.  
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Introduction 
1.1 The bacterial cell envelope 
The cell envelope of Gram-negative bacteria prevents harmful compounds from entering 
the bacterial cell, maintains the cell’s rigidity and shape, and allows entry of nutrients [1, 
2]. The cell envelope consists of an inner membrane, a peptidoglycan layer, and an outer 
membrane (Figure 1). The inner membrane is a phospholipid bilayer composed primarily 
of phospholipids and integral membrane proteins. Phosphatidylethanolamine and 
diphosphatidylethanolamine are the most abundant lipids in the inner membrane. The 
enzymes responsible for the synthesis of peptidoglycan and select outer membrane 
components are major proteins located in the inner membrane, in addition to secretion 
systems, efflux pumps, membrane sensor kinases, and components of the respiratory 
chain [3].   
Glycan chains of N-acetylglucosamine and N-acetylmuramic acid cross-linked by a 
short polypeptide form a net-like polymeric structure known as cell wall peptidoglycan or 
murein. The chemistry of cross-links and the peptide composition vary between bacterial 
species (reviewed in [4]). Essential for cell survival, the peptidoglycan cell wall 
maintains cell integrity by withstanding internal turgor (osmotic) pressure. Also, the 
peptidoglycan layer acts as a scaffold for other cell envelope components, such as the 
peptidoglycan-associated lipoprotein that anchors the outer membrane to the 
peptidoglycan [2].  
The outer membrane is an asymmetric bilayer composed of phospholipids, 
lipoproteins, polysaccharides such as capsular polysaccharides (CPS or capsule), 
enterobacterial common antigen (ECA), lipopolysaccharide (LPS), and proteins, and is  
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Figure 1. Schematic representation of the Gram-negative bacterial cell envelope (Modified from [5]). 
The cell envelope consists of 3 layers: the inner membrane (IM), the periplasmic space, including the 
peptidoglycan, and the outer membrane (OM). Proteins are found in all 3 layers and surface 
polysaccharides like LPS protrude out of the outer membrane into the extracellular space. 
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selectively permeable by preventing the diffusion of macromolecules, neutral and anionic 
substances and hydrophobic molecules [6-8]. The outer membrane confers Gram-
negative bacteria resistance to various bactericidal compounds such as bile salts, 
hydrophobic antibiotics, and detergents [2, 9, 10]. These properties of the outer 
membrane also help the bacteria to evade host defenses such as phagocytosis and 
complement killing [11, 12]. A defining feature of the outer membrane bilayer is its 
asymmetry; the inner leaflet has a similar lipid composition as the inner membrane while 
the outer leaflet has a low concentration of phospholipids with LPS being the dominant 
structural component [2, 9, 10].    
 
1.2 Lipopolysaccharides 
1.2.1 Structure of LPS 
 LPS is a heat-stable and negatively charged surface glycolipid that has 3 structural 
components: lipid A, core oligosaccharide (OS), and O-antigen (OAg). LPS is anchored 
to the outer leaflet of the outer membrane by the hydrophobic lipid A portion, which is 
also the most conserved LPS moiety (reviewed in [13]; Figure 2). 
 The next most conserved structural component of LPS is the core OS, 
consisting of 8 to 12 sugar residues in total, which can be further subdivided into an inner 
core and outer core. Rare sugars like Kdo and L- or D-glycero-D-manno-heptose are 
characteristic of the inner core OS (reviewed in [14]), and modifications, like 
phosphorylation, are common to the inner core heptoses. D-glucose (Glc), D-galactose 
(Gal), D-glucosamine (GlcN), N-acetylglucosamine (GlcNAc), and N-
acetylgalactosamine (GalNAc) are common hexoses found in the outer core OS. 
  5 
 
 
 
 
 
Figure 2. General structure of lipopolysaccharide (Modified from [5]). The three main structural 
components of LPS are: the lipid A, the core oligosaccharide, including the inner and outer core, and the O-
antigen. Kdo = α-3-deoxy-D-manno-oct-2-ulosonic acid; n= number of O units. 
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The outer core OS is the site of attachment for the OAg, which is the most surface 
exposed LPS structural component.  
The OAg is also the most heterogeneous structural component of LPS. In E. coli 
alone, 170 serologically different OAg molecules have been identified [15]. OAg is a 
polymer of polysaccharide subunits or O units, which are composed of unique 
monosaccharides (reviewed in [16]) and can be linear or branched. Due to the variation in 
types of sugars, their sequence in the subunit, and the type of linkages between sugars, 
there are numerous possible O unit structures. Therefore, OAgs are highly variable across 
species and even strains. Additional variability exists through modifications such as 
acetylation or glycosylation. The variation in the OAg structure accounts for a wide range 
of serotypes in Gram-negative bacterial species.  
 
1.2.2 LPS biosynthesis 
 The lipid A-core and OAg are synthesized in separate biosynthetic pathways. The 
core OS is assembled onto preformed lipid A by sequential glycosyltransfer reactions 
while OAg is assembled onto undecaprenyl-phosphate (Und-P) forming an Und-PP-
linked saccharide. Both synthesis pathways are initiated at the cytoplasmic face of the 
inner membrane and require a translocation step to the periplasmic face of the inner 
membrane. MsbA, an inner membrane ATP Binding Cassette (ABC)-transporter, is 
responsible for the transport of the lipid A-core across the inner membrane (reviewed in 
[13]) while the OAg biosynthesis, initiated by WecA, will be discussed in section 1.3. 
Once both molecules are translocated across the inner membrane to the periplasmic face, 
they become ligated together with the release of Und-PP.  Und-PP is then 
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dephosphorylated into Und-P by a poorly characterized but conserved pathway. Finally, 
the complete LPS molecule is transported through the periplasmic space and then onto 
the outer leaflet of the outer membrane by the Lpt pathway [17].  
 
1.3 Biosynthesis and assembly of O-antigen 
 OAg biosynthesis starts at the cytosolic face of the inner membrane with the 
formation of an Und-PP-linked intermediate. All cells produce polyisoprenoids, which 
are lipid carrier intermediates for the biosynthesis of complex carbohydrate structures. 
Polyisoprenol-phosphate-linked saccharides are needed in the early stages of protein 
glycosylation in eukaryotes and prokaryotes, as well as for bacterial cell wall 
peptidogylcan and surface polysaccharide synthesis. Nucleotide sugars, available as 
soluble molecules in the cytosol, donate carbohydrates for the synthesis of the saccharide 
moiety. In contrast, the phosphoisoprenol acceptor is embedded within the lipid 
membrane bilayer. After assembly, the phosphoisoprenol-linked saccharide molecules 
must cross the lipid bilayer for further processing. Therefore, the transmembrane 
movement of phosphoisoprenol-linked saccharides represents a conserved, obligatory 
step of significant biological importance in all types of cells [17-21].  
 Depending on the specific type of assembly system, the Und-PP-OAg is 
subsequently elongated, translocated across the membrane, and polymerized, ultimately 
resulting in an Und-PP-linked polymeric OAg localized to the periplasmic side of the 
inner membrane. Finally, the OAg glycan moiety becomes ligated onto the lipid A-core 
OS resulting in the formation of a complete LPS molecule while the Und-PP 
polyisoprenoid carrier is dephosphorylated into Und-P by several membrane-associated 
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phosphatases and recycled to reinitiate OAg biosynthesis [17-20, 22, 23]. Two main 
pathways are responsible for the assembly of OAg: the Wzy/Wzx-dependent pathway 
and various types of ABC-transporter-dependent pathways.  
 
1.3.1 Wzy/Wzx-dependent O-antigen biosynthesis 
 The Wzy/Wzx pathway involves the synthesis of O-units by the successive 
addition of monosaccharides at the non-reducing end of the molecule. This pathway is 
responsible for the synthesis of the majority of OAgs, and especially heteropolymeric 
OAgs. Wzx is an inner membrane protein with 12 predicted TMs that translocates the O-
units across the inner membrane. Wzx proteins share little primary sequence similarity 
such that they can be used as genetic markers for distinguishing among specific OAgs. 
Wzy polymerizes the translocated O-units. Polymerization proceeds sequentially from the 
reducing end of the growing polymer to the non-reducing end of Und-PP-linked units. 
Wzy proteins are also inner membrane proteins with 11-13 predicted TMs and also share 
little sequence similarity. Unlike Wzx, Wzy proteins from different O-types are not 
interchangeable and display specificity for the O-unit. Several Wzy proteins were 
examined with topology prediction programs and it appears that Wzy proteins possess a 
large periplasmic loop that may be important in the recognition of the OAg subunit.  
The third component to the Wzy/Wzx-dependent pathway is the chain-length 
regulating protein Wzz. These proteins are in the inner membrane, and all have a 
periplasmic loop with a predicted coiled-coil structure flanked by two TMs. Wzz controls 
the degree of polymerization by Wzy and appears not to be specific for a given O-repeat 
subunit structure. It is thought these three proteins work together as a functional complex 
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(Figure 3). Once the OAg molecule is complete, the integral membrane ligase WaaL 
transfers the complete OAg from Und-P ‘en bloc’ onto the pre-formed lipid A-core to 
form a covalent, glycosyl linkage between the two molecules, resulting in a complete 
LPS molecule which is exported to the outer surface of the outer membrane [24-35].  
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Figure 3. Wzy/Wzx-dependent O-antigen biosynthesis pathway in E. coli (Modified from [5]). 
Initiation of OAg biosynthesis occurs at the cytosolic face of the inner membrane. WecA catalyzes the 
phosphoanhydride bond formation between GlcNAc-1P and Und-P to yield Und-PP-GlcNAc. Membrane 
associated glycosyltransferases add additional sugars onto the Und-PP-GlcNAc intermediate forming O 
units. Wzx translocates the O unit across the inner membrane to the periplasmic face where Wzy 
polymerizes the O units together. Wzz regulates the degree of polymerization. Upon completion of 
polymerization, WaaL transfers the OAg from Und-PP to the preformed lipid A-core, and covalently 
ligates the LPS molecule together.  
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1.3.2 ABC transporter-dependent O-antigen biosynthesis 
 The ATP-binding cassette (ABC) transporter pathway translocates the complete 
OAg across the inner membrane in a process that requires ATP hydrolysis. This pathway 
operates primarily in the synthesis of linear, homopolymeric OAg molecules. ABC 
transporters are also involved in the export of lipid-linked glycans for the assembly of 
glycoproteins, teichoic acids, and CPSs. Seven different classes can be identified that 
represent ABC transporter-dependent pathways. Six of these classes consist of 
independent pairs of TM polypeptides and polypeptides containing the nucleotide-
binding domains (NBDs) [17, 36].   
Elongation of the entire OAg occurs at the cytoplasmic face of the inner 
membrane by glycosyltransferases that add sugars to the Und-PP-sugar (Figure 4). Unlike 
Wzy-dependent synthesis, the GlcNAc residue is transferred to lipid A-core OS during 
ligation only once per chain, therefore it is not found within the O-repeat unit structure 
itself. The O-specific polysaccharides formed by this pathway display strain-specific 
chain length (modal) distributions despite that the ABC-transporter dependent pathway 
does not involve a Wzz protein. The chain-terminating WbdD protein modifies the 
nonreducing end of these polymers, causing termination of polymerization, therefore 
controlling the length of these polymers [13, 17, 36].  
ABC-2 transporters contain a TMD component, Wzm, an inner membrane protein 
with an average of six TMs, and a hydrophilic NBD protein, designated as Wzt. Wzm 
homologues display little primary sequence similarity, while Wzt homologues are much 
more highly conserved, especially in the NBD domain. Contrarily, Wzm proteins are 
interchangeable between different OAgs, while Wzt proteins are not. Again, once 
  12 
 
translocated, WaaL mediates ligation of the OAg onto lipid A-core at the periplasmic 
face of the inner membrane [13, 37]. 
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Figure 4. ABC transporter-dependent O-antigen biosynthesis pathway in E. coli (Modified from [5]). 
Initiation of OAg biosynthesis occurs at the cytosolic face of the inner membrane to form the isoprenoid 
linked OAg intermediate. Soluble glycosyltransferases add additional sugars onto the intermediate to 
complete OAg. The ABC transporter, composed of Wzt and Wzm, translocates the complete OAg across in 
the inner membrane to the periplasmic face. WaaL covalently ligates the OAg from Und-P to the preformed 
lipid A-core.  
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1.3.3 Synthase-dependent OAg biosynthesis 
 The O:54 antigen of S. enterica serovar Borreze is the only known example of the 
synthase-dependent O-polysaccharide. The O:54-specific polysaccharide is a linear 
homopolymer of N-acetylmannosamine (ManNAc). Synthases are inner membrane 
proteins that catalyze a vectorial polymerization reaction by a processive mechanism 
resulting in the extension of the polysaccharide chain with the simultaneous extrusion of 
the nascent polymer across the inner membrane. The exact mechanism of elongation, 
translocation, and chain termination are still unknown [17, 36].  
 
1.4 Initiating enzymes 
Two major families of enzymes catalyze the initiation reaction of OAg biosynthesis: 
Polyisoprenyl-phosphate N-acetylaminosugar-1-phosphate transferases (PNPTs) and 
Polyisoprenyl-phosphate hexose-1-phosphate transferases (PHPTs) [36]. See figure 5 for 
a schematic topological comparison of the two major families.  
 
1.4.1 PHPT family 
All PHPT transferases are inner membrane proteins found only in prokaryotes, 
and share a high level of primary sequence similarity. The prototypic enzyme of this 
family is WbaP, which initiates OAg biosynthesis in S. enterica by transferring galactose-
1-phosphate from UDP-galactose (UDP-Gal) to Und-P, yielding Und-P-P-Gal [38-41]. 
WbaP has three domains with five predicted TM helices. The hydrophobic N-terminal 
domain spanning four TMs has no known function but contributes to the overall stability 
of the protein in the membrane [40]. The large, central periplasmic loop between TM 4 
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Figure 5. Schematic representation of the topologies of the PHPT and the PNPT prototypic enzymes. 
Roman numerals indicate the TM helices. Numbers indicate the cytosolic loops. A) Topological 
representation of WbaP from S. enterica serovar Typhi. The topology was predicted using the TMHMM, 
MEMSAT, TOPPRED, and PHD programs. B) Topological representation of WecA from E. coli. The 
model was originally derived using the TMHMM program and the TM boundaries were experimentally 
refined by SCAM [20].  
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and TM 5 is implicated in modulating chain length distribution of OAg [39, 42]. Most 
importantly, the C-terminal domain, including TM5 and the tail, is sufficient for in vitro 
and in vivo enzymatic activity, and its localization was confirmed by trypsin cleavage and 
GFP reporter experiments [39, 42]. Other members of the PHPT family initiate the 
synthesis of various types of glycans such as: colonic acid in E. coli K-12 [39, 42, 43], 
K30 capsule in E. coli 09:K30 [42, 44, 45], type 2 capsule in Streptococcus pneumoniae 
[39, 46, 47], and glycans for S-layer protein glycosylation in Geobacillus 
stearothermophilus [39, 48] and general protein glycosylation [36]. 
 
1.4.2 PNPT family 
The PNPT family of proteins has prokaryote and eukaryote members. PNPT 
enzymes catalyze the transfer of N-acetylaminosugar-1-phosphate from the donor, UDP-
N-acetyl-aminosugar to the lipid acceptor. Und-P is the only lipid acceptor found in 
bacteria, whereas the lipid acceptor in eukaryotes and Archaea is dolichylphosphate (Dol-
P) [49]. Dol-P and Und-P both contain an α-isoprene unit. This is the phosphorylated end 
of the molecule that participates in the phosphoanhydride bond formation with the N-
acetylaminosugar-1-P. Und-P contains 11 isoprene units, all of which are fully 
unsaturated, while Dol-P can be made of 15-19 isoprene units that have a saturated α-
isoprene [50]. Eukaryotic and bacterial evolutionary divergence may be reflected by their 
ability to discriminate their lipid substrate (Figure 6).  
Eukaryotic PNPTs are involved in asparagine N-linked protein glycosylation, 
transferring GlcNAc-1-phosphate from UDP-GlcNAc to Dol-P forming the product  
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Figure 6. Lipid carriers utilized by the PNPT family of enzymes (Modified from [17]). Structure of 
isoprenoid lipids. A) Und-P. B) Dol-P. Und-P has 11 isoprene units and Dol-P has 15-19 isoprene units. 
The α isoprene unit is the one linked to the phosphate mocule. n = number of total isoprene units. 
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Dol-PP-GlcNAc [51-53]. The bacterial PNPT WecA, the prototype for the PNPT family, 
is a UDP-GlcNAc:UndP GlcNAc-1-phosphate transferase. This reaction is involved in 
initiation of OAg and ECA synthesis in enteric bacteria [26, 27, 54-58]. Contrary to other 
PNPT enzymes, WecA has relaxed specificity and can also use UDP-GalNAc [54, 59]. 
Other bacterial PNPTs include WbpL, WbcO, and MraY [59-62]. WbpL and WbcO are 
thought to be specific for UDP-N-acetyl-D-fucosamine (UDP-FucNAc) and/or UDP-N-
acetyl-D-quinovosamine (UDP-N-QuiNAc). MraY proteins initiate peptidoglycan 
synthesis by catalyzing the transfer of N-acetylmuramoyl-pentapeptide 1-phosphate 
(MurNAc-pentapeptide-1P) from UDP-MurNAc-pentapeptide to Und-P forming Und-
PP-MurNAc-pentapeptide. 
Prokaryotic and eukaryotic PNPTs are polytopic inner membrane proteins sharing 
six discrete, conserved domains found in bacterial and eukaryotic homologues [22, 23, 
53, 63-66]. Due to sequence similarity and location at the transmembrane:cytosol 
interface, these domains were proposed to be involved in catalysis or substrate binding 
[53]. The PNPT family members have five cytosolic loops (cytoloops). Conserved 
regions in cytoloops 2, 3, and 4 (including the highly conserved VFMGD motif) are 
found in all bacterial PNPT members and likely contribute to form the catalytic site of 
these enzymes [51, 53, 65, 67]. A high degree of variability was noted in the large 
cytoloop 5, which is proposed to be involved in nucleotide sugar specificity (Figure 7) 
[51, 65].  
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1.5 Structure-function of WecA 
1.5.1 Topology of WecA 
WecA is a 367 amino-acid bacterial sugar-phosphate transferase with a molecular 
mass of 40.9 kDa. The WecA topology was initially predicted in silico using the 
transmembrane hidden Markov model (TMHMM) and compared to known topologies of 
MraY and other PNPT family proteins [20, 22, 51, 67, 68]. Reporter fusions and the 
substituted cysteine accessibility method (SCAM) were utilized to refine the predicted 
model and confirm that WecA has 11 transmembrane helices (TMs), 5 cytoplasmic loops, 
5 periplasmic loops, and a cytosolic C-terminus (Figure 7) [20, 51]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  20 
 
 
 
 
 
 
 
 
 
 
Figure 7. Predicted topology of E. coli MV501 WecA (Modified from [51]).  The N-terminus is in the 
periplasm, the 5 cytoloops are indicated by numbers 1-5, and the C-terminus is in the cytoplasm. The 
dotted-line circle indicates the updated location of the highly conserved VFMGD motif (based on 
biotinylation of aspartic acid 217). The asterisks indicate the controversial residues D35 and R209.Other 
critical residues are indicated by circles with white backgrounds while the squares indicate the periplasmic 
and cytoplasmic controls. 
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1.5.2 Regions of WecA essential for catalysis 
Numerous attempts have been made to define regions and individual amino acids 
in WecA that are functionally significant. TMs I through III are essential for function but 
not for membrane insertion [69]. TM XI is essential for stability of the protein in the 
membrane while the C-terminal tail of WecA is dispensable for function [22]. The highly 
conserved arginine (R) at position 265, and the histidine-isoleucine-histidine-histidine 
(HIHH) motif at positions 279-282 within cytoloop 5 are thought to play a role in UDP-
GlcNAc recognition [22, 65]. The HIHH sequence is reminiscent of the histidine-
isoleucine-glycine-histidine (HIGH) motif conserved in the active site of nucleotide 
phosphate binding proteins, such that amino acid replacements of R265 and the HIHH279-
282 motif resulted in loss of OAg production and binding of the transition state analogue, 
tunicamycin [22, 70, 71]. Replacement of H279 with glycine (G) demonstrated that this 
residue is critical for enzyme function [71].  
Aspartic acid (D) residues at positions 90 and 91 in cytoloop 2, and 156 and 159 
in cytoloop 3 are also conserved in the PNPT family but are functionally distinct [22, 23]. 
The conserved aspartic acids in cytoloop 2 of WecA were proposed to bind the cofactor 
Mg2+, while D156 and D159 were proposed to be involved in UDP-GlcNAc binding or 
modification. Only D156 is essential for catalysis. Amino acid substitutions in all of the 
conserved aspartic acids cause defects in OAg initiation, supporting these hypotheses [20, 
23].  
Eukaryotic and prokaryotic PNPT family members share another highly 
conserved region, the VFMGD motif (Figure 8). This motif in MraY was proposed to 
contain a catalytic nucleophile, D267 [72], while experiments in our laboratory suggest  
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Figure 8 (Modified from [51]). ClustalW alignment of the highly conserved VFMGD motif among PNPT 
family members. Alignment shows protein sequences from E. coli MraY, B. subtilis MraY, H. sapiens 
GPT, Fission Yeast GPT, and E. coliI WecA. An asterisk (*) indicates completely conserved amino acids, 
and a colon (:) indicates partially conserved amino acids. 
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the comparable motif and D217 in WecA does not [51]. The size of the amino acid side 
chains and the polarity at the D217 position are important for enzymatic activity, as were 
the replacements of the surrounding residues with alanine. Therefore this highly 
conserved motif is proposed to define a region in PNPT proteins that contributes to the 
active site [51].  
 
1.6 Methods for predicting and determining inner membrane protein topologies 
Topological methods provide insight into essential amino acids, organization, and 
structure of inner membrane proteins. There are several methods to predict and 
experimentally probe the topology of membrane proteins.  
 
1.6.1 In silico analysis 
The precise identification of TMs is important for the functional annotation and 
the functional analysis when studying any membrane protein. A major obstacle when 
studying membrane proteins is the difficulty in experimental determination of their three-
dimensional structures, especially if no prior topology prediction studies have been 
performed. Experimental studies are therefore complemented, and generally initiated, by 
computational studies using neural networks, Hidden Markov models, and support vector 
machines [73]. Most topology predictions methods, such as the Transmembrane Hidden 
Markov Model (TMHMM), are based on processing multiple-sequence alignment data, 
and several assumptions such that hydrophobic regions are potential TMs, coiled-coil 
regions are potential protein-interaction domains, and hydrophilic stretches are potential 
loops [73, 74]. TM predictions are possible since most TM α-helices contain long 
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stretches of 17-25 non-polar hydrophobic residues. These hydrophobic regions cross the 
lipid membrane many times, and contain connecting loops with more polar residues. The 
orientation of the helices, whether inward or outward, is also important to the overall 
topology of the protein. This is highlighted by the well-established “positive-inside” rule 
that predicts that a hydrophobic region followed by positively charged residues, such as 
arginine and lysine, may indicate an inward orientation of the helix [73-76]. The 
TMHMM program takes advantage of these postulates and is therefore reasonably 
accurate, providing near 80% confidence based on analyses of model membrane proteins 
[73, 75]. In silico methods for predicting membrane protein topology provide a general 
topological model of the protein of interest, especially when different computer programs 
afford similar predictions [68, 73, 76]. However, non-canonical residues in TMs, like 
positively or negatively charged amino acids can lead to wrong predictions. 
 
1.6.2 Reporter fusions 
Topological arrangement of proteins within the bacterial cytoplasmic membrane 
has been successfully studied using gene fusions techniques. The most widely used 
reporters are β-galactosidase (LacZ), and alkaline phosphatase (PhoA).  
The periplasmic alkaline phosphatase PhoA and the cytoplasmic β-galactosidase 
LacZ are reporter proteins that have reciprocal activity in different cellular 
compartments; therefore, these enzymes are used as sensors for the subcellular locations 
of segments of integral membrane proteins (Figure 9). PhoA is only enzymatically active 
when it is translocated across the inner membrane into the periplasmic space. This is 
visualized when the bacteria expressing enzymatically active PhoA appear blue when  
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Figure 9. Schematic representation of the enzymatic activity of reporter fusions. Blue indicates when 
the fusion protein is enzymatically active as the attached hybrid moiety is localized to the correct cellular 
compartment. Bacteria appear blue when grown on medium containing the appropriate substrate. White 
indicates an enzymatically inactive fusions and bacteria will appear colourless. 
 
 
  26 
 
grown on medium containing the substrate analogue X-P. If the PhoA moiety remains in 
the cytosol then the bacteria appear colourless as PhoA is not enzymatically active. 
Contrarily, LacZ is only enzymatically active when this moiety of the hybrid protein 
remains in the cytoplasm. This is visualized when bacteria are grown on medium 
containing the substrate analog X-Gal and appear blue. Again, if LacZ is translocated to 
the periplasm (opposite to PhoA) the bacteria will appear colourless, indicating an 
enzymatically inactive fusion.   
The method of reporter fusions can give inconclusive results. This is most likely 
due to disruption of the tertiary structure of the protein of interest because of truncation 
or alternate conformations, depending on which reporter protein is present. Correct 
topological information is only provided if topogenic signals from the target protein are 
present before the fusion junction to the reporter enzyme [77-80]. Junctions closer to the 
TM borders and even within TMs can lead to false positive and negative results, making 
the accurate topological assignment very difficult. 
 
1.6.3 Substituted cysteine accessibility method (SCAM) 
The analysis of protein structure has been greatly advanced by a technique which 
involves the modification of thiol groups in proteins and is designated SCAM. It is a 
biochemical approach to experimentally determine the topology of inner membrane 
proteins. SCAM allows the residues on the water-accessible surface of membrane 
proteins to be systematically mapped.  It takes advantage of thiol-reacting molecules, 
such as maleimides, combined with membrane-permeable and -impermeable reagents 
that help define the orientation of cytoplasmic residues versus periplasmic residues, in 
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addition to the length and orientation of TM segments. TM residues are prevented from 
reacting with maleimides because of their presence in the hydrophobic space so mutating 
residues around the border of the predicted TM regions can help refine their predicted 
length [81-87]. In the presence of water, the double bond of the maleimide ring breaks to 
form an irreversible thiolate (Figure 10). Maleimide reacts 1,000 times more efficiently in 
a slightly acidic pH range of 6.5-7.5, whereas an increase to above a pH 8 leads to 
reactivity with primary amines, and hydrolysis of the maleimide ring. Thus, maleimides 
are particularly suited for this chemistry as they are virtually unreactive until they 
encounter an available sulfhydryl group [82, 88, 89]. Further, SCAM allows topological 
assessment under conditions in which inner membrane proteins remain properly folded. 
A key point of this methodology is the reliance on a cysteineless protein that remains 
functional, and allows the introduction of single cysteines at specific sites. Single amino 
acid changes are less likely to disrupt tertiary structure of the protein and alter its native 
topology, a problem commonly found with reporter fusions. Therefore, SCAM provides 
the basis for better refinement of the topology of the protein of interest [82, 85, 90, 91]. 
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Figure 10. Schematic representation of the sulfhydryl reaction. Maleimide molecules become reactive 
when they encounter available sulfhydryl groups, such as single cysteines exposed on the protein surface in 
extra membrane loops. In the presence of water, the double bond of the maleimide ring breaks to form an 
irreversible thiolate, while the terminal monomethoxy group prevents cross-linking to other available 
thiols. P = protein of interest; SH = sulfhydryl group (substituted cysteine).  
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The classical SCAM method employs biotin maleimide and a blocker reagent 
such as MTSET. Biotin maleimide is internalized by bacteria and labels available 
cysteines in extramembrane loops, whether in the cytosol or the periplasmic space. 
MTSET is a positively charged, thiol-reactive reagent that because it cannot cross the 
inner membrane blocks periplasmic cysteine residues from biotinylation (Figure 11). 
Cysteine residues in TMs are not labeled due to their hydrophobic environment that 
prevents access of water molecules that are critical for biotinylation. The difficulty with 
this strategy is that the biotinylated protein must be purified prior to detection with 
streptavidin. Purification is critical to separate the modified protein from the background 
of other native proteins in the membrane that became biotinylated in their native 
cysteines. Therefore, this classical biotinylation method for SCAM can give considerable 
background, and is highly labour-intensive and time consuming [20, 51, 92]. An 
alternative strategy based on PEGylation overcomes this shortcoming and will be 
discussed in the next section. 
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Figure 11. Schematic representation of SCAM (Modified from [82]). A protein of interest containing a 
single substituted cysteine either to the periplasmic (left half of the circle) or cytoplasmic (right half of the 
circle) side of the membrane is expressed in cells. Membrane preparations result in inside-out orientated 
vesicles (ISOV), which are opposite orientations for the same cysteines. Half of the cells or ISOV is reacted 
with a detectable thiol reagent to label the periplasmic exposed cysteine and the other half is reacted with 
blocking thiol reagent to protect the periplasmic-exposed cysteines in consequent labeling steps. To 
specifically label cytoplasmic cysteines, the latter half of cells or ISOV is permeabilized to expose the 
cytoplasmic cysteines to react with a detectable thiol reagent. The detectable thiol reagent is used to track 
the labeled target protein from analyzed cells and ISOV. Note ISOV patterns of cysteine labeling (+) and 
blocking (-) are mirror image of the whole cell patterns.  
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1.7 PEGylation 
PEGylation also employs maleimide reagents, but eliminates the need for protein 
purification. In this method, the cysteine residues are modified by the covalent 
attachment of poly(ethylene) glycol (PEG). PEG is a hydrophilic and linear, or branched, 
polyether terminated with hydroxyl or functional groups. Monomethoxy PEG is the most 
useful for modification when defining inner membrane protein topologies as it prevents 
cross-linking from occurring.  
PEG-Mal has a molecular mass of 5 kDa and is membrane-impermeable. Using 
ethylenediaminetetracetic acid (EDTA) to permeabilize the outer membrane, PEG-Mal is 
able to react with periplasmic residues of the protein in otherwise intact cells. EDTA 
chelates the divalent metal ions of LPS to create a more permeable outer membrane but 
still maintains the structure and organization of the bacterial cell envelope [93, 94]. Upon 
crossing the EDTA-permeabilized outer membrane, PEG-Mal forms an irreversible 
thiolate with any available periplasmic substituted cysteine. To asses if a substituted 
cysteine is exposed to the cytoplasm, membrane preparations are performed before PEG-
Mal labeling. Membrane preparations give a mix of membrane vesicles where 
cytoplasmic substituted cysteines become exposed and are therefore available to react 
with PEG-Mal. It is only TM substituted cysteines, buried in the hydrophobic space, that 
are unable to form a thiolate with PEG-Mal. The PEG bulk creates an apparent band shift 
of 10-25 kDa detectable by western blot, indicating that WecA has been modified [89, 
93, 95] (Figure 12).  
 
 
  33 
 
 
 
 
  34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Schematic representation of PEGylation and the theoretical Western blots based on 
labeling pattern. In EDTA-permeabilized cells only periplasmic-exposed cysteines react with PEG-Mal 
and show a band-shift. In membrane preparations cysteines on either side of the inner membrane react with 
PEG-Mal and show a band-shift. TM residues orientated into the lipid bilayer are do not react with PEG-
Mal and do not show a band-shift.  
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1.8 Research objectives 
1.8.1 Rationale 
The topological model of the E. coli WecA was originally derived using the 
TMHMM computer software and was experimentally refined by SCAM based on 
biotinylation [20, 82]. From this information WecA was predicted to consist of 11 
transmembrane domains (TMs), 5 periplasmic and 5 cytoplasmic loops, with the N-
terminus located in the periplasm and the C-terminus in the cytoplasm (Refer to Figure 
1). The cytoplasmic location of the C-terminus was independently confirmed by GFP 
fusion [17, 18, 20].  
However, WecA is difficult to over-express and purify, resulting in inconsistencies in 
the biotin labeling experiments. Furthermore, functional residues detected by 
mutagenesis are spread over several different cytoloops of the protein [5, 20], making the 
need to determine the border of the TMs and cytoloops even more critical. Therefore, the 
central goal of this research project was to determine the boundaries between specific 
TMs and cytoloops with a reliable thiol labeling method such as PEGylation, which 
bypasses the need for a purification step. 
 
1.8.2 Specific Objectives 
This thesis has two specific objectives: 
1) To optimize the PEGylation assay in WecA. To address this objective, I first 
demonstrated that PEGylation is specific and predictive of the topological location of the 
targeted residue. The former was accomplished using increasing PEG-Mal concentrations 
in labeling experiments performed on the cysteineless WecA (negative control) and 
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WecA mutants with cysteine residues in periplasmic, membrane and cytoplasmic regions, 
which were previously established by biotin-SCAM. The aim was to demonstrate that 
PEG-Mal only labels available periplasmic cysteines in intact (EDTA-permeabilized) 
cells but can also label cytoplasmic exposed cysteines in membrane preparations.  
2) To refine the borders between cytoloops 1 and 4, and their corresponding 
TMs, and to better characterize TMs IV and V. This objective involved creating 
additional single substituted cysteine mutants in WecA in the areas of interest. 
Translocation of each mutant derivative to the membrane was confirmed by Western blot 
and complementation of OAg production in E. coli MV501 in vivo was verified. Finally, 
the PEGylation assay was employed to refine the orientation of the substituted residues.  
 
 
 
  
 
 
 
 
 
 
 
Chapter 2 
 
 
 
Material and Methods 
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2.1 Bacterial strains, growth conditions, and reagents 
 The bacterial strains and plasmids used in this study are listed in Table 1. Bacteria 
were grown at 37°C in Luria-Bertani (LB) medium supplemented with ampicillin (100 
µg/mL) and/or tetracycline (20 µg/mL) and/or 0.2% (w/v) arabinose, as appropriate. 
Chemicals were purchased from Sigma (St. Louis, MO, USA), unless otherwise stated. 
Enzymes were purchased from Agilent Life Sciences and Chemical Analysis (Santa 
Clara, CA, USA), New England Biolabs (Massachusetts, USA) and Roche Diagnostics 
(Laval, QC, Canada). Oligonucleotide primers for sequencing and site-directed 
mutagenesis (listed in Table 2) were purchased from Eurofins MWG Operon (Huntsville, 
AL, USA). The QIAprep Spin Miniprep Kit by Qiagen (ON, Canada) and the High-
Speed Plasmid Mini Kit by Geneaid (New Taipei City, Taiwan) were used to isolate 
plasmids.  
 
2.2 Site-directed mutagenesis 
2.2.1 Plasmid isolation 
 Plasmids were isolated by a small-scale plasmid DNA preparation. Briefly, 5 mL 
overnight cultures (16 h at 37° using orbital shaking at 200 rpm) of E. coli DH5α 
containing the appropriate plasmids were pelleted by centrifugation using a 1.5-mL 
microcentrifuge tube at 16 000 x g for one min (repeated until the entire culture were 
harvested). The supernatant was aspirated and the bacterial cell pellet was resuspended in 
200 µL of PD1 Buffer (with RNase A). Two hundred µL of PD2 Buffer was added and 
the tube was inverted to gently mix the suspension without shearing genomic DNA and 
incubated at room temperature for at least 2 min, or until the lysate was homogeneous.  
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Table 1. Bacterial strains and plasmids used in this study 
Strain or Plasmid Relevant Properties  Reference or Source 
E. coli Strains   
DH5α E. coli K-12 F-Φ80lacZΔ M15 
endA recA 
hsdR(rK- mK-) supE thi gyrA relA 
Δ(lacZYA-argF)U169 
Laboratory stock 
MV501 VW187; wecA::Tn10 TcR [57] 
Plasmids   
pBAD24 Cloning vector [96] 
pJL7 pKV1 expressing cysteineless 
WecA 
[20] 
pJL8 pJL7 expressing WecA-D35C [20] 
pJL15 pJL7 expressing WecA-F143C [20] 
pJL19 pJL7 expressing WecA-G181C [20] 
pJL20 pJL7 expressing WecA-R209C [20] 
pJL29 pJL7 expressing WecA-S362C [20] 
pSEF39 pJL7 expressing WecA-Y211C [51] 
pSEF34 pJL7 expressing WecA-V213C [51] 
pSEF35 pJL7 expressing WecA-M215C [51] 
pSEF36 pJL7 expressing WecA-D217C [51] 
pSEF37 pJL7 expressing WecA-S220C [51] 
pSLL1 pJL7 expressing WecA-L4C This study 
pSLL2 pJL7 expressing WecA-S7C This study 
pSLL3 pJL7 expressing WecA-S12C This study 
pSLL4 pJL7 expressing WecA-L19C This study 
pSLL5 pJL7 expressing WecA-A24C This study 
pSLL6 pJL7 expressing WecA-K30C This study 
pSLL7 pJL7 expressing WecA-K41C This study 
pSLL8 pJL7 expressing WecA-L46C This study 
pSLL9 pJL7 expressing WecA-S54C This study 
pSLL10 pJL7 expressing WecA-F61C This study 
pSLL11 pJL7 expressing WecA-V66C This study 
pSLL12 pJL7 expressing WecA-Y69C This study 
pSLL13 pJL7 expressing WecA-A73C This study 
pSLL14 pJL7 expressing WecA-L77C This study 
pSLL15 pJL7 expressing WecA-L83C This study 
pSLL16 pJL7 expressing WecA-R25C This study 
pSLL17 pJL7 expressing WecA-V27C This study 
pSLL18 pJL7 expressing WecA-Q44C This study 
pSLL19 pJL7 expressing WecA-G45C This study 
pSLL20 pJL7 expressing WecA-Q104C This study 
pSLL21 pJL7 expressing WecA-V107C This study 
pSLL22 pJL7 expressing WecA-V110C This study 
pSLL23 pJL7 expressing WecA-M112C This study 
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pSLL24 pJL7 expressing WecA-F114C This study 
pSLL25 pJL7 expressing WecA-K116C This study 
pSLL26 pJL7 expressing WecA-Y118C This study 
pSLL27 pJL7 expressing WecA-S120C This study 
pSLL28 pJL7 expressing WecA-L122C This study 
pSLL29 pJL7 expressing WecA-Y124C This study 
pSLL30 pJL7 expressing WecA-L133C This study 
pSLL31 pJL7 expressing WecA-F136C This study 
pSLL32 pJL7 expressing WecA-F139C This study 
pSLL33 pJL7 expressing WecA-T141C This study 
pSLL35 pJL7 expressing WecA-I149C This study 
pSLL38 pJL7 expressing WecA-I47C This study 
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Next, 300 µL of PD3 Buffer was added and mixed gently by inversion before 
centrifuging at 16 000 x g for 10 min. The supernatant was added to a PD column, which 
was placed in a 2-mL collection tube, and was centrifuged at 16 000 x g for 30 sec. The 
flow-through was discarded and 400 µL of W1 Buffer was added to the PD column and 
then centrifuged at 16 000 x g for 30 sec. Again, the flow-through was discarded and 600 
µL of Wash Buffer (ethanol added) was added to the PD column and then centrifuged at 
16 000 x g for 30 sec. The flow-through was discarded one more time before centrifuging 
the PD column/collection tube at 16 000 x g for 3 min to dry the column matrix. The 
dried PD column was transferred to a clean microcentrifuge tube and 50 µL of Elution 
Buffer was added to the centre of the column matrix. After incubation at room 
temperature for at least 2 min, or until the Elution Buffer was completely absorbed, the 
tube was centrifuged at 16 000 x g for 5 min to elute the DNA. 
 
2.2.2 Agarose gel electrophoresis 
 DNA fragments were separated by agarose gel electrophoresis on 0.8% agarose 
gel (w/v) prepared in 1X TBE buffer (90 mM Tris-Borate, 1 mM EDTA [pH 7.5]) 
supplemented to a final concentration of 0.0005 mg/mL ethidium bromide. DNA samples 
were loaded with 10X DNA agarose loading dye (50% glycerol [v/v], 0.1% bromophenol 
blue [w/v], 100 mM EDTA [pH 7.5]), and the gels were subjected to electrophoresis at 
100 V. A 1-kilobase pair (kb) or 100-base pair (bp) molecular weight GeneRule DNA 
Ladder Marker (MBI Fermentas, Burlington, ON, Canada) was loaded in each gel as 
DNA fragment size reference. DNA gels were visualized using a GelDoc 2000 Imaging 
Unit and digitally processed with Multi-Analyst software (Bio-Rad, Hercules, CA, USA). 
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2.2.3 Polymerase Chain Reaction (PCR) with Pfu Turbo DNA polymerase 
 WecA derivatives with single amino acid replacements were constructed with the 
Quik-Change Site Directed Mutagenesis Kit by Stratagene (Agilent Life Sciences and 
Chemical Analysis [Santa Clara, CA, USA]). The forward and reverse primer pairs 
(Table 2) were designed to create the plasmids pSLL1 through pSLL38 encoding the 
proteins listed in Table 1. The 38 individual mutations were made in the parental 
WecAFLAG-7xHis gene (plasmid pJL7) expressing cysteineless WecA. See figure 13 for the 
locations of the mutations indicated on the topological map of WecA. The PCR reactions 
were prepared by mixing 1 µL of pJL7 template, 1 µL of dNTP mix (10 mM), 5 µL of 
10X Pfu Turbo reaction buffer, 39.5 µL of double-distilled water (ddH2O), and 1.5 µL of 
the forward and reverse primers of choice. Then, 0.5 µL of Pfu Turbo DNA polymerase 
was added to each reaction volume (~50 µL) and PCR thermal cycling was performed 
using a Bio-Rad Dyad Peltier Thermal Cycler. The PCR program involved an initial 30 
sec denaturation at 95°C followed by 16 subsequent cycles of denaturation at 95°C for 30 
sec, primer annealing at 55°C for 1 min, and extension at 68°C for 12 min. The PCR 
reactions were digested overnight with 1 µL of the restriction enzyme DpnI at 37°C to 
degrade any residual pJL7 plasmid DNA. Successful PCR amplification of pre- and post-
DpnI PCR products were verified by agarose gel electrophoresis as described above in 
section 2.2.2. Next, 5 µL of confirmed products were introduced by transformation into 
chemically competent DH5α E. coli as described below in section 2.4.1. Plasmids were 
isolated from transformed colonies and the correct mutation confirmed by DNA 
sequencing using the oligonucleotide primers 252 and 258 (Table 2). Colonies with the  
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Table 2. Oligonucleotide primers used in this study 
WecA strain 
and mutants 
Primer Sequence* 
 
WecAL4C 
 
6325 
6326 
 
5’ – ACATATGAATTTATGTACAGTGAGTACT  
5’ – AGTACTCACTGTACATAAATTCATATGT 
  
WecAS7C 6327 
6328 
5’ – TTACTGACAGTGTGTACTGATCTCATC 
5’ – GATGAGATCAGTACACACTGTCAGTAA 
 
WecAS12C 6329 
6330 
5’ – ACTGATCTCATCTGTATTTTTTTATTC 
5’ – GAATAAAAAAATACAGATGAGATCAGT 
 
WecAL19C 6331 
6332 
5’ – TTATTCACGACATGTTTTCTGTTTTTT 
5’ – AAAAAACAGAAAACATGTCGTGAATAA 
 
WecAA24C 6333 
6334 
5’ – TTTCTGTTTTTTTGTCGTAAGGTGGCA 
5’ – TGCCACCTTACGACAAAAAAACAGAAA 
 
WecAR25C 6650 
6651 
5’ – TCTGTTTTTTGCCTGTAAGGTGGCAAAA 
5’ – TTTTGCCACCTTACAGGCAAAAAACAGA 
 
WecAK26C 6861 
6862 
5’ – TTTTTTGCCCGTTGTGTGGCAAAAAAA 
5’ – TTTTTTTGCCACACAACGGGCAAAAAA 
 
WecAV27C 6652 
6653 
5’ – TTTGCCCGTAAGTGTGCAAAAAAAGTC 
5’ – GACTTTTTTTGCACACTTACGGGCAAA 
 
WecAK30C 6335 
6336 
5’ – AAGGTGGCAAAATGTGTCGGTTTAGTG 
5’ – CACTAAACCGACACATTTTGCCACCTT 
 
WecAK41C 6337 
6338 
5’ – CCAAACTTCCGCTGTCGTCACCAGGGA 
5’ – TCCCTGGTGACGACAGCGGAAGTTTGG 
 
WecAQ44C 6654 
6655 
5’ – CGCAAACGTCACTGTGGATTGATACCT 
5’ – AAGTATCAATCCACAGTGACGTTTGCG 
 
WecAG45C 6656 
6657 
5’ – AAACGTCACCAGTGTTTGATACCTCTC 
5’ – GAGAGGTGTCAAACACTGGTGACGTTT 
 
WecAL46C 6359 
6360 
5’ – CGTCACCAGGGATGTATACCTCTCGTT 
5’ – AACGAGAGGTATACATCCCTGGTGACG 
 
WecAI47C 6863 
6864 
5’ – CACCAGGGCTTGTGTCCTCTCGTTGGG 
5’ – CCCAACGAGAGGACACAATCCCTGGTG 
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WecAS54C 
 
6361 
6362 
 
5’ – GTTGGGGGGATTTGTGTTTACGCAGGG 
5’ – CCCTGCGTAAACACAAATCCCCCCAAC 
 
WecAF61C 6363 
6364 
5’ – GCAGGGATTGCCTGTACGTTCGGAATT 
5’ – AATTCCGAACGTACAGGCAATCCCTGC 
 
WecAV66C 6365 
6366 
 
5’ – ACGTTCGGAATTTGTGATTACTATATT 
5’ – AATATAGTAATCACAAATTCCGAACGT 
 
WecAY69C 6367 
6368 
5’ – ATTGTCGATTACTGTATTCCGCATGCA 
5’ – TGCATGCGGAATACAGTAATCGACAAT 
 
WecAA73C 6369 
6370 
5’ – TATATTCCGCATTGTTCTCTCTATCTC 
5’ – GAGATAGAGAGAACAATGCGGAATATA 
 
WecAL77C 6371 
6372 
5’ – GCATCTCTCTATTGTGCTGCTGCCGGT 
5’ – ACCGGCAGCAGCACAATAGAGAGATGC 
 
WecAL83C 6373 
6374 
5’ – GCTGCCGGTGTGTGTGTTTTCATTGGC 
5’ – GCCAATGAAAACACACACACCGGCAGC 
 
WecAQ104C 6658 
6659 
5’ – CGTGCCACCATATGTGCCGCTGTTGGC 
5’ – GCCAACAGCGGCACATATGGTGGCACG 
 
WecAV107C 6660 
6661 
5’ – ATACAGGCCGCTTGTGGCATTGTTATG  
5’ – CATAACAATGCCACAAGCGGCCTGTAT 
 
WecAV110C 6662 
6663 
5’ – GCTGTTGGCATTTGTATGATGGTGTTC 
5’ – GAACACCATCATACAAATGCCAACAGC 
 
WecAM112C 6699 
7000 
5’ – GGCATTGTTATGTGTGTGTTCGGCAAG 
5’ – CTTGCCGAACACACACATAACAATGCC 
 
WecAF114C 6664 
6665 
5’ – GTTATGATGGTGTGTGGCAAGCTTTAT 
5’ – ATAAAGCTTGCCACACACCATCATAAC 
 
WecAK116C 6701 
6702 
5’ – ATGGTGTTCGGCTGTCTTTATCTCAGT 
5’ – ACTGAGATAAAGACAGCCGAACACCAT 
 
WecAY118C 6666 
6667 
5’ – TTCGGCAAGCTTTGTCTCAGTAGCCTG 
5’ – CAGGCTACTGAGACAAAGCTTGCCGAA 
 
WecAS120C 6703 
6704 
5’ – AAGCTTTATCTCTGTAGCCTGGGTTAT 
5’ – ATAACCCAGGCTACAGAGATAAAGCTT 
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WecAL122C 
 
6705 
6706 
 
5’ – TATCTCAGTAGCTGTGGTTATATCTTT 
5’ – AAAGATATAACCACAGCTACTGAGATA 
 
WecAY124C 6707 
6708 
5’ – AGTAGCCTGGGTTGTATCTTTGGCTCC 
5’ – GGAGCCAAAGATACAACCCAGGCTACT 
 
WecAG127C 6865 
6866 
5’ – GGTTATATCTTTTGTTCCTGGGAGATG 
5’ – CATCTCCCAGGAACAAAAGATATAACC 
 
WecAL133C 6709 
6710 
5’ – TGGGAGATGGTGTGTGGACCGTTTGGT 
5’ – ACCAAACGGTCCACACACCATCTCCCA 
 
WecAF136C 6668 
6669 
5’ – GTGCTCGGACCGTGTGGTTACTTCCTG 
5’ – CAGGAAGTAACCACACGGTCCGAGCAC 
 
WecAF139C 6670 
6671 
5’ – CCGTTTGGTTACTGTCTGACGCTATTT 
5’ – AAATAGCGTCAGACAGTAACCAAACGG 
 
WecAT141C 6711 
6712 
5’ – GGTTACTTCCTGTGTCTATTTGCCGTC 
5’ – GACGGCAAATAGACACAGGAAGTAACC 
 
WecAI149C 6674 
6675 
5’ – GTCTGGGCGGCCTGTAATGCGTTCAAC 
5’ – GTTGAACGCATTACAGGCCGCCCAGAC 
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Figure 13. Additional amino acid substitution locations in WecA (Modified from [51]). The WecA 
topological model originally predicted with TMHMM and experimentally refined using SCAM was used as 
a guideline for the selection of amino acids to mutate to cysteine. Black circles indicate critical residues 
previously determined [22, 23, 69]. Black squares indicate the periplasmic (G181C) and cytoplasmic 
(S362C) controls. Blue circles indicate mutations created in this study. Red circles indicate previous 
mutations created that are tested in this study [20, 51, 92]. Bolded numbers indicate cytoplasmic loops.  
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plasmids containing the desired amino acid replacements were stored in stock solution 
(20% glycerol [v/v], 20% LB [w/v], ddH2O) at -80°C. 
 
2.2.4 DNA sequencing 
 DNA sequencing was performed by the Core Molecular Biology Facility, York 
University, ON, Canada and/or Eurofins MWG Operon, Huntsville, AL, USA. 
 
2.3 Competent cell preparation 
2.3.1 DH5α chemically competent cells 
 E. coli DH5α chemically competent cells were made by the rubidium chloride 
(RbCl2) method adapted from Sambrook et al. [97]. From a frozen stock, a 5 mL 
overnight culture of DH5α cells was grown. The overnight culture was added to 150 mL 
of Super Optimal Broth (SOB) supplemented with 1.5 mL of 2 M Mg2+ and incubated 
until an optical density (OD600) of 0.6 to 0.8 was reached. The culture was transferred to 
sterile 25-mL plastic Nalgene tubes and chilled on ice for 15 min. Cells were harvested 
by centrifugation at 5927 x g for 10 min at 4°C. The pellet was resuspended in 50 mL of 
Buffer 1 (100 mM RbCl2, 50 mM MnCl2·4H2O, 30 mM potassium acetate [pH 7.5], 10 
mM CaCl2·2H2O, and 15% glycerol [v/v] adjusted to a final pH of 5.8 with 0.2 M acetic 
acid), placed on ice for 15 min, and centrifuged again. The pellet was resuspended in 12 
mL of Buffer 2 (10 mM RbCl2, 75 mM CaCl2·2H2O, 10 mM MOPS, and 15% glycerol 
[v/v] adjusted to a final pH of 6.8 with NaOH) and placed on ice for another 15 min. 
Finally, cells were aliquoted into 200 µL fractions in 1.5 mL microcentrifuge tubes and 
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were flash-frozen in an ethanol/dry ice bath. Chemically competent DH5α cell were 
stored at -80°C until needed. 
 
2.3.2 MV501 electrocompetent cells 
 Starting from a frozen stock, a 5 mL overnight culture of MV501 cells was grown 
supplemented with tetracycline. The overnight was inoculated into 25 mL of LB with an 
adjusted optical density (OD600) of 0.1 and grown for approximately 1 h, until the optical 
density (OD600) reached 0.5 to 0.6. The culture was then chilled on ice for 10 min and 
transferred to a sterile 25-mL plastic Nalgene tube. The cells were harvested by 
centrifugation at 5927 x g for 10 min at 4°C. The supernatant was decanted and the pellet 
was resuspended in 5 mL of cold, sterile ddH2O and centrifuged again at 5927 x g for 10 
min at 4°C. Next, the supernatant was decanted and the pellet was resuspended in 1 mL 
of cold, sterile ddH2O before being divided into two aliquots in 1.5-mL microcentrifuge 
tubes, and topped up to 1 mL with cold, sterile ddH2O. The cells were harvested in the 
tabletop centrifuge at 16 000 x g and resuspended in 1 mL of cold, sterile ddH2O. This 
step was repeated once more before the final pellet was resuspended in 500 µL of 20% 
glycerol/ddH2O. Electrocompetent MV501 cells were aliquoted into 50 µL volumes and 
frozen at -80°C until needed. 
 
2.4 Transformation of E. coli strains 
2.4.1 Transformation of DH5α chemically competent cells 
 Chemically competent cells were thawed on ice and 5 µL of the PCR product was 
added and mixed gently. The cells were left on ice for 30 min before heat-shock at 42°C 
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for 2 min in a water bath. Then, 800 µL of SOC media was added to each aliquot and the 
cells were incubated at 37°C for 2 h. One hundred twenty five µL of the recovered cell 
suspension was spread on LB-Agar plates supplemented with ampicillin and left 
overnight at 37°C.  
 
2.4.2 Transformation of MV501 electrocompetent cells 
 Electrocompetent cells were thawed on ice and 2 µL of the appropriate plasmid 
was added and mixed gently. The aliquots were transferred to chilled electroporation 
cuvettes (Bio-Rad, CA, USA) and shocked at 1.25V using a Bio-Rad Gene Pulser to 
obtain a time constant of at least 4. The cells were recovered in 800 µL of SOC medium 
at 37°C for 2 h in a water bath. Then, 100 µL of the recovered cell suspension was spread 
on LB-Agar plates supplemented with ampicillin and tetracycline and left overnight at 
37°C. 
 
2.5 Protein expression 
2.5.1 Isolation of total membrane proteins 
 Five-mL cultures of MV501 transformed with a plasmid containing parental or 
mutated wecA were incubated overnight at 37°C in LB supplemented with ampicillin and 
tetracycline. The overnight cultures were inoculated into 25 mL flasks of LB with an 
adjusted optical density (OD600) of 0.1 and grown for approximately 1.5 h, until mid-
logarithmic phase, where the optical density (OD600) reached 0.5 to 0.6. At this time 
point, transcription of the plasmid-encoded wecA was induced by arabinose at a final 
concentration of 0.2%, followed by incubation at 37°C for 3 h. Cells were harvested by 
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centrifugation at 9 300 x g for 10 min at 4°C, washed with 0.9% NaCl, and pelleted again 
at 9 300 x g for 10 min at 4°C. The cells were resuspended in 2 mL of 50 mM TAE 
buffer (50 mM Tris-acetate [pH 8.5], 1 mM EDTA), supplemented with 80µL of 
Complete-EDTA-free protease inhibitor, transferred to 15-mL Falcon tubes, and lysed 
with the Constant Systems Ltd (UK) cell disruptor set to the “one shot” mode at 27 000 
Psi. Cell debris was pelleted by centrifugation at 17 418 x g for 15 min at 4°C. Next, the 
supernatant was transferred to microcentrifuge tubes and total membranes were pelleted 
by ultracentrifugation at 30 966 x g for 35 min at 4°C. The membranes were resuspended 
in 10 µL of TAE buffer and total protein concentration of the fractions was measured 
immediately (see below). 
 
2.5.2 Quantification of total membrane proteins 
 The concentration of protein in the total membrane fractions was measured using 
the Bio-Rad Protein Assay, a modified Bradford Assay. One µL of membrane preparation 
was diluted into 799 µL of ddH2O and 200 µL of Bio-Rad Protein Assay Dye for a final 
volume of 1 mL. Similarly, standards containing 0, 2, 4, 6, 8, and 10 µg of bovine serum 
albumin (BSA) were prepared. The absorbance of the standards and the membrane 
preparations was measured at 595 nm. The values obtained from the standards were used 
to construct a standard curve from which total protein concentration of each membrane 
preparation was extrapolated.  
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2.5.3 Detection of WecA and WecA mutant derivatives 
 Wild type WecA and the WecA mutants contained a C-terminal FLAG epitope so 
that the proteins could be detected by Western blot analysis. A previously described 
protocol was adapted to first resolve the proteins by gel electrophoresis [98]. Volumes of 
membrane preparations containing 5-10 µg of total protein were combined with 3X 
protein dye (0.875 M Tris [pH 6.8], 6% [w/v] SDS, 30% [v/v] glycerol, 0.03% [w/v] 
bromophenol blue, 15% [v/v] β-mercaptoethanol) and separated by 14% Tris-glycine 
SDS-PAGE (Running Gel: 14% ABA 44:0.8, 0.2% SDS, 0.375 M Tris-HCl [pH 8.0], 
0.025% ammonium persulfate [APS], 0.025% N,N,N’,N’-tetramethylehtylenediamine 
[TEMED]; Stacking Gel: 4.5% ABA 44:0.8, 0.1% SDS, 0.125 M Tris-HCl [pH 6.8], 
0.025% APS, 0.025% TEMED) electrophoresis in 1X SDS buffer (25 mM Tris [pH 7.6], 
200 mM glycine, 2.3 mM SDS) using the Mini-Protean 3 Cell (Bio-Rad, CA, USA) at 
110-120V until the dye front ran through the stacking gel then increased to 130-150V. A 
pre-stained Broad-Range Molecular Weight Marker (Bio-Rad) was included on all gels 
as a molecular mass standard. Electrophoresis was performed until the dye front reached 
the bottom of the protein gel.  
 Next, using the Bio-Rad Transblot system, proteins were transferred to 
nitrocellulose membranes (Pall Life Sciences, Pensacola, FL). Briefly, the protein gel, a 
nitrocellulose membrane, & blotting papers (VWR, UK), both cut to the size of the gel 
were assembled as described elsewhere [97]. The transfer was performed in chilled 
Transfer Tris-Glycine Buffer (25 mM Tris, 190 mM glycine, 0.1% SDS, 20% methanol) 
at 250 mA for 1 h. After disassembling the transfer system, the nitrocellulose membranes 
were washed with Tris Buffered Saline (TBS) (1 M Tris-HCl [pH 7.7] and 5 M NaCl). 
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Then, the membranes were blocked overnight in Western Blocking Reagent (Roche) 
diluted in TBS in a cold room. The following day, the membranes were rinsed with TBS 
then incubated for at least 1.5 h in TBS with 1:10 000 Anti-FLAG M2 monoclonal 
(mouse) antibody (Sigma, MO, USA) by rocking at room temperature. Next, the 
membranes were washed with TBS three times for 10 min each by rocking at room 
temperature. The membranes were incubated for at least 15 min in TBS with 1:20 000 
Alexa Fluor 680 anti-mouse antibody and 700µL of Western Blocking Reagent by 
rocking at room temperature. After 3 more washed with TBS, the membranes were 
developed using the Odyssey V3.0 infrared imagining by Licor (Li-Cor, Lincoln, NB). 
 
2.6 LPS production 
2.6.1 LPS isolation 
 Previously described protocols were modified to isolate LPS from whole bacterial 
cells [99, 100]. Parental MV501 or derivatives transformed with a plasmid parental or 
mutated wecA were grown overnight as 5 mL cultures in LB supplemented with 
ampicillin and tetracycline and 0.002% arabinose. The optical density (OD600) was 
measured and the turbidity was adjusted to 2 in a final volume of 1.5 mL in 1X PBS. 
From the normalized cell suspensions, whole cells were harvested by centrifugation at 16 
000 x g in a tabletop centrifuge for 1 min at room temperature. The pellets were 
resuspended in 150 µL of LPS Lysis Buffer (2% SDS, 4% β-mercaptoethanol, 10% 
glycerol, 1 M Tris [pH 6.8], 0.01% bromophenol blue) and boiled for 10 min. Ten µL of 
proteinase K (20 mg/mL) was added to the lysate, followed by vortexing and incubation 
at 60°C in a water bath for 2 h. Then, 150 µL of pre-warmed 95% phenol was added and 
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each sample was incubated at 70°C in a water bath for 15 min with vortexing every 5 
min. Samples were then cooled on ice for 15 min before centrifugation at 16 000 x g for 
10 min at room temperature to separate the aqueous phase containing the free LPS from 
the phenol phase containing any residual cellular components. Next, the clear phase was 
transferred to a clean microcentrifuge tube and 500 µL of ether was added to remove any 
residual phenol by mixing it with the aqueous phase by gentle inversion. The samples 
were centrifuged at 16 000 x g for 1 min at room temperature and the ether phase was 
aspirated. LPS preparations were stored at -20°C. 
 
2.6.2 Gel electrophoresis (Tricine SDS-PAGE) 
 Three µL of LPS was mixed with 3 µL of 3X protein dye and resolved by gel 
electrophoresis in a 14% Tricine SDS-PAGE (Running Gel: 28.4% A-6-BA [49.5% 
acrylamide-6% bisacrylamide], 33.2% gel buffer (3 M Tris [pH 8.5], 0.3% SDS), 10.4% 
[v/v] glycerol, 0.2% APS, and 0.12% TEMED; Stacking Gel: 3.9% A-3BA [49.5% 
acrylamide-3% bisacrylamide], 24.5% gel buffer, 1% APS, and 0.44% TEMED) using 
the Mini-Protean 3 Cell (Bio-Rad). Gels were run at 50V through the stacking gel (~ 30 
min) and 130V through the running gel until it ran off (~ 2 h), then run for 20 more min 
in a two-buffer system (anode buffer (0.2 M Tris [pH 8.9]) and cathode buffer (0.1 M 
Tris [pH 8.25], 0.1% SDS)).  
 
2.6.3 LPS Silver Staining 
 After electrophoresis, gels were fixed overnight in a 60% methanol, 10% acetic 
acid solution in order to visualize the LPS using a modified version of a previously 
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described silver stain protocol [101]. Gels were rehydrated in a 7.5% acetic acid solution 
with rocking for 30 min at room temperature. Next, the gels were oxidized in a 0.2% 
solution of periodic acid with rocking for 30 min at room temperature. The gels were 
washed three times with ddH2O for 10 min. A silver staining solution (0.18% sodium 
hydroxide, 1.4% ammonium hydroxide and 19.4% silver nitrate) was applied for 15 min 
followed by three more washed with ddH2O for 10 min. The gels were developed in a 
0.05% citric acid, 10% methanol, 0.019% formaldehyde solution until the LPS banding 
pattern appeared. The developing process was stopped quickly by three more washes 
with ddH2O for 10 min. Images of LPS banding patterns were created by scanning the 
gels using the HP Scanjet 4070 Photosmart Scanner.  
 
2.7 PEGylation 
2.7.1 Preparation of EDTA-permeabilized cells for labeling 
 Five-mL cultures of MV501 transformed with a plasmid containing parental or 
mutated wecA were incubated overnight at 37°C in LB supplemented with ampicillin and 
tetracycline. The overnight cultures were inoculated into 100 mL flasks of LB 
supplemented again with ampicillin and tetracycline with an adjusted optical density 
(OD600) of 0.1 and grown for approximately 1.5 h, until mid-logarithmic phase, where the 
optical density (OD600) reached 0.5 to 0.6. At this time point, transcription (protein 
expression) of the plasmid-encoded wecA was induced by arabinose at final concentration 
of 0.2% and the cells were further incubated at 37°C for 3 h. Whole cells were harvested 
by centrifugation at 9 300 x g for 10 min at 4°C, washed with 5 mL of HEPES/MgCl2 
Buffer (50 mM HEPES [pH 6.8], 5 mM MgCl2), and pelleted again at 9 300 x g for 10 
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min at 4°C. At this point, the pellets were resuspended in 1 mL of HEPES/MgCl2 and the 
optical density (OD600) was measured, before being aliquoted in microcentrifuge tubes 
into volumes with a normalized OD of 5. The cells were pelleted again in at 16 000 x g 
for 1 min then resuspended in 100µL of HEPES/MgCl2 Buffer with 5 mM of 0.5 M 
EDTA and 1 mM of 10 mM PEG-Mal. The reaction was allowed to proceed for one h at 
room temperature before being quenched with 45 mM of 0.5 mM DTT for 10 min at 
room temperature. The labeled cells were pelleted by centrifugation for 5 min, the 
supernatant was removed, and the pellets were frozen at -20°C until use. Cell pellets were 
thawed on ice before being resuspended in 1 mL of HEPES/MgCl2 Buffer supplemented 
with 40 µL of Complete EDTA-free protease inhibitor (Roche). Cells were lysed and 
total membrane preparations were collected following the protocol described above 
(section 2.5.1) and resuspended in 10 µL of HEPES/MgCl2 Buffer.  
 
2.7.2 Preparation of total membrane fractions for labeling 
 Five-mL cultures of MV501 transformed with a plasmid containing parental or 
mutated wecA were incubated overnight at 37°C in LB supplemented with ampicillin and 
tetracycline. The overnight cultures were inoculated into 100 mL flasks of LB 
supplemented again with ampicillin and tetracycline with an adjusted optical density 
(OD600) of 0.1 and grown for approximately 1.5 h, until mid-logarithmic phase, where the 
optical density (OD600) reached 0.5 to 0.6. At this time point, transcription (protein 
expression) of the plasmid-encoded wecA was induced by arabinose at final concentration 
of 0.2% and the cells were further incubated at 37°C for 3 h. Whole cells were harvested 
by centrifugation at 9 300 x g for 10 min at 4°C, washed with 5 mL of HEPES/MgCl2 
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Buffer and pelleted again at 9 300 x g for 10 min at 4°C. At this point, the pellets were 
resuspended in 1 mL of HEPES/MgCl2 and the optical density (OD600) was measured, 
before being aliquoted in microcentrifuge tubes into volumes with a normalized OD of 5. 
The cells were pelleted again in at 16 000 x g for 1 min then the supernatant was removed 
and the pellets were frozen at -20°C until use. Cell pellets were thawed on ice before 
being resuspended in 1 mL of HEPES/MgCl2 Buffer supplemented with 40 µL of 
Complete EDTA-free protease inhibitor (Roche). Cells were lysed and total membrane 
preparations were collected following the protocol described above (section 2.5.1). The 
membranes were resuspended in 20 µL aliquots of HEPES/MgCl2 Buffer with 1 mM of 
10 mM PEG-Mal and the reaction was allowed to proceed at room temperature for one h 
before being quenched with 45 mM of 0.5 M DTT for 10 min. The labeled membranes 
were pelleted by centrifugation for 5 min and resuspended in 10 µL of HEPES/MgCl2 
Buffer.  
 
2.7.3 Detection of PEGylated WecA 
 Parental WecA and the WecA mutants were detected by Western blot as 
described above (section 2.5.3). PEGylated WecA resulted in a band shift of 
approximately 10- to 25-kDa gain in apparent mass relative to parental WecA, producing 
a characteristic double-band (see figure 11 again for reference).  
 
2.8 Statistics 
 The data and figures are representative of typical experiments which were 
repeated at least twice in each case.
  
 
 
 
 
 
 
 
 
 
Chapter 3 
 
 
Results 
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3.1 Rationale for this study 
 The current topological model of the E. coli WecA encompasses 11 TMs, five 
periplasmic and five cytoplasmic loops, with the N-terminus located in the periplasm and 
the C-terminus in the cytoplasm [17, 18, 20]. Several residues in cytoloops 2, 3 and 4 are 
conserved among PNPT family members. Cytoloop 5, the least conserved, is thought to 
recognize the carbohydrate moiety of the nucleotide sugar substrate (Figure 7). This 
model was derived from a combination of in silico approaches and biotin-SCAM [20, 51, 
92]. The classical biotin-SCAM method relies on protein purification to separate the 
protein of interest from other native, unmodified proteins that contain exposed cysteines, 
which can also be labeled. Because the WecA protein is difficult to purify we employed 
SCAM combined with PEGylation. In this method, the cysteine residues are modified by 
the covalent attachment of poly(ethylene) glycol and the labeled proteins can be readily 
detected by Western blot by an increase in their apparent molecular mass. This approach 
simplifies the analysis of cysteine-replaced mutant WecA proteins. 
 This research was aimed at optimizing the PEGylation protocol for WecA and 
defining the borders between cytoloops 1 and 4, and their corresponding TMs, as these 
cytoloops contain residues that are important for enzymatic activity. Moreover, TMs IV 
and V also have residues predicted to interact with Und-P. 
 
 
 
 
 
  59 
 
3.2 Expression of WecA mutant enzymes in total membrane fractions 
 Amino acid substitutions, especially in the TMs, can lead to improper protein 
folding and degradation. Therefore, SDS-PAGE and Western Blot were used to verify 
that the mutant proteins constructed in this work are properly targeted to the membrane 
and expressed at similar levels as the parental WecA. Typically, mutant proteins that 
cannot properly insert in the membrane cannot be detected in membrane preparations or 
they are barely detectable, suggesting protein degradation. Analysis of total membrane 
fractions from bacteria expressing the 38 single-cysteine WecA mutants constructed here 
were detectable by Western blot, revealing a polypeptide with an apparent mass of 36 
kDa (Figure 14). These experiments also revealed a higher molecular weight band 
corresponding to a WecA aggregate that is routinely seen under our experimental 
conditions due to the mild denaturation required for visualization of membrane proteins 
[69]. The single-cysteine mutant proteins were expressed at comparable levels to that of 
parental WecA, although some variation between mutants can be attributed to loading 
differences. 
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Figure 14. Expression of WecA mutant derivatives. Total membrane fractions were prepared from E. 
coli MV501 transformed with plasmids encoding wecA mutants. Bacteria were grown until mid-
exponential phase and protein expression was induced by arabinose. Cells were harvested, lysed, and the 
membrane protein fractions were isolated by ultracentrifugation, and a sample of each mutant (5-10µg of 
protein) was separated by 14% SDS-PAGE. Proteins were transferred to a nitrocellulose membrane, and 
WecA was detected by anti-FLAG, with Alexa Fluor 680 anti-mouse used as secondary antibody. The 
positions of the molecular mass markers are indicated on the left, the mutations on top (L=ladder), and the 
protein monomers and aggregates on the right.  
 
 
 
 
  61 
 
3.3 Complementation of O-antigen production by WecA mutant enzymes 
 A protein that is topologically correct should also be functional unless the Cys 
either replaces a catalytic residue or causes a localized structural perturbation affecting 
enzyme function. Therefore, we examined the effects of the single-cysteine mutations on 
OAg production by in vivo complementation of E. coli strain MV501 containing a 
wecA::Tn10 insertion. MV501 competent cells were transformed with plasmids encoding 
wecA or one of the wecA substituted cysteine mutants. LPS was isolated from the 
transformants and visualized by silver staining as described in Materials and Methods 
(Figure 15). The amount of OAg produced by each mutant was compared to parental 
WecA. K41C, A73C, Q104C, L122C, F136C, and F139C WecA proteins mediated much 
less polymeric OAg, while M112C, K116C, and T141C fail to complement. These 
differences, compared to parental WecA (pJL7), would suggest diminished in vivo 
function. However, the differences could also be due to loading differences, as the mutant 
proteins are stably inserted in the membrane. Similar observations were made with the 
previously constructed mutants D35C and F143C [20, 92].  
Furthermore, similar results were also observed with the replacement of various 
aromatic residues with conservative, polar mutations located in TMs IV and V, the 
putative polyisoprenol recognition sequence (PIRS motif). The PIRS motif is predicted to 
be in transmembrane spanning regions and involved in specific interactions between the 
hydrophobic residues of the motif and the isoprenoid [5, 102]. If Und-P interacts with 
WecA at this site by multiple hydrophobic interactions, then increasing the polarity of the 
contact region should result in a proportional decrease in polymeric OAg production. 
While the mutants constructed by E. Haggerty, a previous M.Sc. student in our  
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Figure 15. Complementation of OAg production by wild-type WecA and mutant derivatives. LPS was 
isolated from E. coli MV501 transformed with a plasmid encoding either wecA or a wecA mutant. LPS 
structural components were resolved by electrophoresis on a 14% Tricine SDS-PAGE, which was fixed 
overnight and silver stained. The plasmids pJL7 and pBAD24 represent the positive and negative controls, 
respectively.  
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laboratory, were not cysteine-substitutions, the polar conservative mutations, such as 
phenylalanine and tryptophan to tyrosine and phenylalanine, did affect polymeric OAg 
production, especially in multiple-residue mutant constructs, indicating that they play a 
role in WecA function [5]. Similarly, cysteine is a polar, non-conservative mutation that 
could also increase the polarity of the region. Therefore, various cysteine substitutions in 
TMs IV and V appear to also diminish polymeric OAg production supporting the idea 
that multiple residues in this area play a role in WecA function. 
 
3.4 PEGylation of WecA mutants 
3.4.1 Optimization 
PEGylation is a relatively recent approach for bacterial inner membrane proteins 
[89, 93, 95, 103, 104]. Therefore, it was necessary to optimize PEGylation of WecA 
before proceeding to the full characterization of the panel of mutants. First, we assessed 
the specificity of the label to make sure it could only detect exposed cysteine residues in 
the protein. The method employed is simplified to include labeling of EDTA-
permeabilized cells and membrane preparations. The previously used and experimentally 
determined periplasmic control, G181C, was compared to the negative, cysteineless 
WecA encoded by pJL7 [20, 51]. Each control was labeled with increasing 
concentrations of PEG-Mal to demonstrate that PEGylation is functional and to 
determine the necessary amount of PEG-Mal that was required to obtain a band-shift. 
While 0.5 mM PEG-Mal was sufficient to visualize a detectable band-shift by Western 
blot, we chose to use 1 mM PEG-Mal in the labeling reactions to ensure there was 
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enough reagent available to PEGylate available cysteines in EDTA-permeabilized cells 
(Figure 16).  
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Figure 16. PEG-Mal labeling of cysteine-substituted WecA of E. coli in crude membrane 
preparations. The various cysteine-substituted mutants were disrupted by a cell disruptor set at 27 kPsi. 
The crude membrane fractions were isolated by ultracentrifugation and divided into four 20 µL aliquots. 
One aliquot was incubated with HEPES/NaCl buffer alone, whereas the remaining three aliquots were 
incubated with increasing concentrations of PEG-Mal (5 kDa). The reaction was quenched by addition of 
45mM DTT, and a sample of each aliquot (5-10 µg of protein) was separated by 14% SDS-PAGE. Proteins 
were transferred to nitrocellulose membrane, and WecA was detected by anti-FLAG, with Alexa Fluor 680 
anti-Mouse used as secondary antibody. The positions of the molecular mass markers are indicated on the 
left. G181C = periplasmic cysteine (should label with PEG-Mal); pJL7 = cysteine-less (should not label 
with PEG-Mal). 
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Second, we used additional replacements of known topology to evaluate if the 
PEGylation occurs as expected. The periplasmic control (G181C) should be labeled with 
the membrane-impermeable PEG-Mal in an EDTA-permeabilized cell, and in membrane 
preparations, and the PEG bulk will create an apparent band shift on a Western blot. The 
cytoplasmic control S362C should not be labeled with the membrane-impermeable PEG-
Mal in EDTA-permeabilized cells, and not cause a band shift on a Western blot. 
Contrarily, S362C should be labeled with PEG-Mal in membrane preparations and cause 
a band shift as membrane preparations create mixed inverted vesicles allowing 
cytoplasmic exposed and bordering TM residues to react with PEG-Mal [20, 22, 23, 51, 
92]. Finally, based on the topological prediction and experimental results employing 
SCAM, we chose F143C as the TM control [20]. F143C is predicted to be buried in a 
hydrophobic space and it was not accessible to biotinylation [20]; therefore, it should not 
react with PEG-Mal.  
Both periplasmic (G181C) and cytoplasmic (S362C) controls reacted with PEG-
Mal as expected. G181C showed an additional PEGylated double-band on Western blots 
in EDTA-permeabilized cells and in membrane preparations. S362C was not labeled in 
EDTA-permeabilized cells but showed a band-shift in membrane preparations. F143C 
was not labeled in EDTA-permeabilized cells, as expected. However, this residue 
consistently and repeatedly showed a double-band in membrane preparations (Figure 17). 
This suggests that F143C is partially exposed to the cytosol, or is at least facing outwards 
from the lipid bilayer, so that PEG-Mal can react with the substituted cysteine in the 
presence of water.  
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Despite that the expected "TM control" denoted a residue that was accessible 
from the cytosol (see below), the results with the periplasmic- and cytoplasmic-exposed 
residues confirmed their previously predicted location. Therefore, the optimization 
experiments suggested that PEGylation is an attractive alternative to biotin-SCAM, as it 
eliminates the need for purification.  
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Figure 17. PEG-Mal labeling of cysteine-substituted WecA in E. coli controls in EDTA-permeabilized 
cells. The various cysteine-substituted mutants were grown until mid-exponential phase until protein 
expression was induced by arabinose. Cells were harvested and resuspended in 1mL of HEPES/MgCl2 
buffer and divided into aliquots of an OD of 5. One aliquot was incubated with incubated with 1mM PEG-
Mal (5 kDa) and 5mM EDTA. The reaction was quenched by addition of 45mM DTT, then the membrane 
protein fractions were isolated by ultracentrifugation, and a sample of each aliquot (5-10µg of protein) was 
separated by 14% SDS-PAGE. The other aliquot was treated with 1mM PEG-Mal (5 kDa) after the 
membrane protein fractions were isolated, and then the reaction was quenched with 45mM DTT before a 
sample of each aliquot (5-10µg of protein) was separated by 14% SDS-PAGE. Proteins were transferred to 
nitrocellulose membrane, and WecA was detected by anti-FLAG, with Alexa Fluor 680 anti-Mouse used as 
secondary antibody. The positions of the molecular mass markers are indicated on the left, the condition on 
the top, aggregates, monomers and PEGylated WecA on the right, and PEGylated WecA mutant derivatives 
at the bottom. pJL7 = cysteine-less WecA (negative control); G181C = periplasmic cysteine; F143C = TM 
cysteine; S362C = cytoplasmic cysteine. 
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3.4.2 Cytoloop 1 
In a previous study [19], the topological location of aspartic acid 35 differed 
experimentally from the in silico prediction. Biotin-SCAM suggested that this residue is 
located in the periplasm, in contrast to the location in cytoloop 1 predicted in silico. Also, 
replacement of aspartic acid 35 with cysteine or glycine resulted in reduced OAg 
production in E. coli MV501 and also reduced enzymatic activity in vitro, suggesting this 
residue plays a role in WecA function [20, 23]. Therefore, it was important to determine 
the location of Asp-35 as well defining the boundaries of cytoloop 1. For this purpose, 
several replacements were made in residues of the predicted cytoloop 1, which included: 
A24C, R25C, V27C, K30C, D35C, K41C, Q44C, G45C, and L46C (Figure 18). More 
specifically, A24C and R25C do not show labeling in intact cells or membrane 
preparations, suggesting they are within TM I. V27C does not show any labeling in intact 
cells but does in membrane preparations suggesting a cytoplasmic orientation.  
Poor expression of Q44C and G45C may indicate that these residues are located 
at the border of TM II, which can cause the protein to be unstable and can make the 
PEGylation results inconclusive. Mutating these residues to alanine should restore the 
stability of the protein, indicating that they are important to WecA stability and are 
located at the TM border. K30C, D35C, K41C, and L46C all label in membrane 
preparations, but not intact cells, again suggesting a cytoplasmic orientation. Therefore, 
K30C, D35C and K41C are located in the cytoplasm, matching the predicted location. 
Q44C, G45C, and L46C are most likely found at the border of TM II, as predicted, 
although labeling of L46C suggests that it is exposed to the cytoplasm. This could be due  
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Figure 18. PEG-Mal labeling of cytoloop 1 of E. coli cysteine-substituted WecA in EDTA-
permeabilized cells and crude membrane preparations. Samples were prepared and blotted as described 
above in figure 17. The positions of the molecular mass markers are indicated on the left, aggregates, 
monomers and PEGylated WecA on the right, and WecA derivatives on the top of each blot. pJL7 = 
cysteine-less WecA; G181C = periplasmic control; S362C = cytoplasmic control  
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to L46C being partially exposed to the cytosol, as it is located at the border of the TM 
and is therefore available to react with PEG-Mal [89]. These results demonstrate the 
specificity and sensitivity of the PEGylation method, and support the predicted 
cytoplasmic orientation of the D35 residue. 
 
3.4.3 TMs I, II and III 
 Additional single-cysteine mutations were created throughout TMs I, II and III in 
the WecA protein, as these regions have not been thoroughly investigated. The mutations 
include: L4C, S7C, S12C, L19C, S54C, F61C, V66C, Y69C, A73C, L77C, and L83C. 
Based on the PEGylation results in EDTA-permeabilized cells and membrane 
preparations, all the residues are located in their predicted locations, except L4C which 
could potentially be included within the boundary of TM I based on the lack of band-shift 
pattern in EDTA-permeabilized cells (Figure 19). Interestingly, L4C and S7C show a 
faint band-shift in membrane preparations indicating some exposure to PEG-Mal. This is 
most likely due to their proximity to the N-terminus of WecA as membrane preparations 
create mixed inverted vesicles such that any residues close to the edge of the TM border 
can be partially exposed and therefore available to interact with PEG-Mal. This is also 
seen with V66C and A73C in membrane preparations while Y69C is labeled in EDTA-
permeabilized cells supporting its predicted periplasmic orientation. Therefore, with the 
exception of residues located at the TM borders that may account for the band-shift 
patterns seen in membrane preparations, PEGylation supports the predicted locations of 
all the residues in TMs I, II and III. In addition, the results provide experimental 
refinement supporting the topological assignment of this region. 
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Figure 19. PEG-Mal labeling of TMs I, II, and III of E. coli cysteine-substituted WecA in EDTA-
permeabilized cells and crude membrane preparations. Samples were prepared and blotted as described 
above in figure 17. The positions of the molecular mass markers are indicated on the left, aggregates, 
monomers and PEGylated WecA on the right, and WecA derivatives on the top of each blot. pJL7 = 
cysteine-less WecA; G181C = periplasmic control; S362C = cytoplasmic control  
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3.4.4 TMs IV and V  
 Currently, there is little known about the physical interaction between isoprenoids 
and their enzymes. The direct interaction between Und-P and WecA had not been 
demonstrated even though molecular modeling techniques have revealed specific 
interactions between hydrophobic residues in the PIRS peptides and the isoprenoids of 
other proteins. Residues located in TMs IV and V are of interest as they are in an 
arrangement that resembles a putative PIRS motif [102, 105, 106]. Both TMs are rich in 
aromatic residues, and we have previously speculated they may be partially exposed to 
the cytoplasm creating an interaction site (“pocket”) with the α-isoprene unit of Und-P 
[5]. Previous experimental attempts show complementation defects and transferase assays 
as support for the hypothesis that Und-P interacts with WecA, however kinetic analyses 
remain inconclusive [5]. This is largely due to the fact that WecA cannot be purified to 
homogeneity in a large enough quantity to perform these functional analyses. Therefore, 
another objective of this study was to utilize the PEGylation protocol to support the 
hypothesis that Und-P interacts specifically with WecA via multiple hydrophobic 
interactions, as purification is not required. In fact, PEGylation of this region facilitates 
additional desired structural information of WecA. So, most of the residues mutated 
along TMs IV and V were originally predicted to be part of the putative PIRS motif [5] in 
addition to other surrounding residues in this region.  
V107, V110, M112 and F114 label in membrane preparations but not in EDTA-
permeabilized cells suggesting exposure to the cytosol. Q104 is PEGylated in membrane 
preparations, confirming it is on the edge of the cytoplasmic border of TM IV (Figure 
20).  
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Figure 20. PEG-Mal labeling of TMs 4 and 5 (PIRS motif) of E. coli cysteine-substituted WecA in 
EDTA-permeabilized cells and crude membrane preparations. Samples were prepared and blotted as 
described above in figure 17. The positions of the molecular mass markers are indicated on the left,  
aggregates, monomers and PEGylated WecA on the right, and WecA derivatives on the top of each blot. 
pJL7 = cysteine-less WecA; G181C = periplasmic control; S362C = cytoplasmic control.  
 
 
 
 
 
 
 
 
  75 
 
K116 does not label in either condition, confirming its predicted location in TM IV and 
most likely facing into the lipid bilayer. Next, Y118 does not label in EDTA-
permeabilized cells but does show a band-shift in membrane preparations suggesting it is 
exposed and part of the PIRS motif. Next, S120, L122 and Y124 show a band-shift in 
both conditions suggesting that these residues are outside on TM IV and exposed to the 
periplasm (Figure 19). It is quite possible with the way WecA could be folded and tilted 
in the membrane that this part of TM IV is exposed.   
The TM V residues L133, F136, F139 and I149 do not label in EDTA-
permeabilized cells but do label in membrane preparations suggesting exposure from the 
cytoplasm. T141 does not show a band-shift in either condition confirming its predicted 
TM location and is therefore facing into the bilayer. F143 shows a band-shift in 
membrane preparations, and is therefore also exposed to the cytoplasm (as discussed 
above in section 3.4.1). This can be further supported by the fact that F143C does not 
complement OAg production [20, 92] and is therefore a critical residue for WecA 
function.  
 
 
3.4.5 Cytoloop 4 (VFMGD motif) 
Arginine 209 [20, 92] and the highly conserved VFMGD motif  [51] include 
additional controversial regions that differed experimentally from the predicted topology. 
R209 was predicted to be in the cytosol while SCAM placed it in the periplasm. 
Contrarily, the VFMGD motif was predicted to be in TM VIII although it was thought to 
have a catalytic nucleophile based on modeling against the VFMGD motif in MraY [51, 
72]. It is now partially reassigned to the cytosol as biotinylation of aspartic acid 217 
provided indications of a cytosolic location. However, the other residues were 
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inaccessible to biotinylation, making their topological assignment difficult. Additional 
experiments indicate that the highly conserved VFMGD motif is likely a region in PNPT 
proteins that is involved in the binding and/or recognitions of the nucleotide moiety of the 
nucleoside phosphate precursor by contributing to the active site [51].  
Using this information, residues R209C, Y211C, V213C, M215C, D217C, and 
S220C were assessed with the PEGylation protocol. None of these substituted cysteine 
residues label in EDTA-permeabilized cells, but they label in membrane preparations, 
suggesting the entire region is located in the cytoplasm (Figure 21). Based on the labeling 
pattern, S220C may be right at the edge of TM VIII as its band-shift is less intense 
compared to the other cytoplasmic residues but is still partially exposed to cytosol, 
allowing it to react with PEG-Mal [89]. The PEGylation results support the proposed 
cytoplasmic orientation of the VFMGD motif. This location is consistent with the 
proposed role of the region in the binding and/or recognition of nucleotide moiety as it 
would need to be exposed to the cytosol to interact with the nucleoside phosphate 
precursor. Additionally, if all the residues of this highly conserved region are located in 
the cytoplasm then the positively charged R209, two residues away, cannot be in the 
periplasm. Therefore, PEGylation of R209C supports the predicted cytosolic location.  
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Figure 21. PEG-Mal labeling of cytoloop 4 of E. coli cysteine-substituted WecA in EDTA-
permeabilized cells and crude membrane preparations. Samples were prepared and blotted as described 
above in figure 17. The positions of the molecular mass markers are indicated on the left, aggregates, 
monomers and PEGylated WecA on the right, and WecA derivatives on the top of each blot. pJL7 = 
cysteine-less WecA; G181C = periplasmic control; S362C = cytoplasmic control  
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Discussion 
Elucidating the topology of WecA and uncovering critical functional residues in 
this protein provides a template to better understand the mechanism of action of PNPT 
family members. This study involved working with WecA in its native environment at 
the inner membrane. Currently, the structural characterization of PNPTs has been 
hampered by difficulties encountered with their overexpression and purification [18, 92]. 
Many previous topological methods miss important biological interactions (in silico), 
disrupt secondary structure of the protein (reporter fusions), and require purification 
(SCAM with biotinylation). PEGylation provides the advantage that it does not require 
protein purification, as it allows direct detection of labeled cysteine residues by a 10-25 
kDa shift in the apparent mass of the protein in its native membrane location.  
Aspartic acid 35 and arginine 209 are examples of WecA residues that differed 
experimentally from the predicted topology. The biotin-SCAM suggested that both 
residues were located in the periplasm, while the topology software predicted a cytosolic 
location [20, 92]. Replacement of aspartic acid 35 with cysteine resulted in loss of 
complementation (O7 LPS synthesis in E. coli MV501) [20, 92]. PEGylation results of 
this work support a cytoplasmic location of both D35 and R209 as these residues only 
labeled with PEG-Mal in membrane preparations, and not EDTA-permeabilized cells. 
We interpreted the differences between biotinylation-SCAM and PEGylation-SCAM as 
due to protein denaturation during purification. 
Additional mutations were created along predicted cytoloop 1, including the 
borders of TMs I and II, to experimentally define the boundaries of the loop and the 
borders of the adjacent TMs. The borders of TM I can be updated to include L4, A24 and 
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R25 within the TM while V27 is located in the cytoplasm. This demonstrates the 
sensitivity and specificity of PEGylation as only one residue K26 separated the 
cytoplasmic border of TM I. At the other end of cytoloop 1 Q44, G45, and L46 are all 
labeled in membrane preparations, and not EDTA-permeabilized cells, indicating a 
cytoplasmic orientation and again refining the border to TM II.  
Next, the highly conserved VFMGD motif was experimentally assessed with 
PEGylation as it is now partially located in the cytosol as previous biotinylation of 
aspartic acid 217 greatly changed the putative TM boundaries. The other residues were 
inaccessible to biotinylation, and may be in the TM, while the border on the other side of 
the VFMGD motif remains unrefined [51]. Again, using PEGylation, the entire region of 
substituted cysteines can be placed within cytoloop 4. Even S220 is labeled, albeit not as 
strongly, indicating that the cytoplasmic border of TM VIII can be updated. Moreover, all 
the substituted cysteines in the VFMGD motif and surrounding area tested with 
PEGylation provided conclusive results, unlike previous experimental attempts using 
biotinylation.  
Initially, F143C was chosen as a control residue in a TM location because 
previous experimental evidence using SCAM with biotinylation suggested it was 
inaccessible. When labeling F143C with PEG-Mal in EDTA-permeabilized cells, there 
was no observable band-shift, as expected for a transmembrane location. However, 
F143C was consistently and reproducibly labeled in PEGylated membrane preparations. 
Previous research in our laboratory has suggested that F143 might be part of a region 
corresponding to a potential Und-P binding site [5], which spans TMs IV and V. These 
two TMs contains an unusual density of bulky aromatic residues, such as phenylalanine 
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and tryptophan, which may be important in interacting with the Und-P lipid substrate by 
creating a "pocket" accessible from the cytoplasm. Our results also suggest that these 
residues in both TMs would face each other rather than establishing interactions with 
membrane glycerophospholipids, which will make the residues inaccessible to PEG-Mal 
labeling.  
After the experimental work in this study was completed, we submitted the WecA 
amino acid sequence to the iterative threading assembly refinement (I-TASSER) server 
for ab initio three-dimensional (3D) modeling. I-TASSER is an integrated web-based 
platform for fully automated protein structure and function prediction. It generates a 3D 
atomic model from multiple threading alignments and iterative structural assembly 
simulations using an amino acid sequence without the common biochemical limits set by 
human intervention. Structurally matching the 3D model with other known proteins 
allows the function of the protein of interest to be inferred. Full-length secondary and 
tertiary structure predictions and functional annotations on ligand-binding sites are some 
of the usual outputs from a typical server. Moreover, I-TASSER is consistently ranked as 
the best method for computational structural biology [107, 108]. 
Comparing the PEGylation results with the 3D model demonstrated a remarkable 
agreement between experimental data and the ab initio structural prediction. The 
experimentally assigned location of nearly every residue that was mutated to cysteine and 
PEGylated agreed with the structural model. Moreover, the structural model supported 
the hypothesis that many of the residues located in TMs IV and V, especially the 
phenylalanines form a "cavity" opened to the cytoplasmic space, which could 
accommodate the lipid carrier. Additionally, the three residues S120, L122, and Y124 at 
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the border of TM IV that show a band-shift in EDTA-permeabilized cells are supported 
by the model to be exposed to the periplasm in loop 2 (see Appendix A). This recent 
automated 3D model is well supported by the current experimental data, suggesting that 
PEGylation is sensitive, specific and accurate method to elucidate the topology of a 
membrane protein like WecA. 
In summary, the PEGylation approach employed here has allowed us to 
characterize and refine the topology of WecA. Currently, four other integral membrane 
proteins are being topologically mapped in our laboratory using the PEGylation protocol 
including E. coli WaaL, Pseudomonas aeruginosa WaaL, E. coli WcaJ, and Burkholderia 
cenocepacia ArnT. 
 
 
 
 
 
 
 
 
  83 
 
References 
 
1. Nikaido, H., Prevention of drug access to bacterial targets: permeability barriers 
and active efflux. Science, 1994. 264(5157): p. 382-8. 
2. Nikaido, H. and M. Vaara, Molecular basis of bacterial outer membrane 
permeability. Microbiol Rev, 1985. 49(1): p. 1-32. 
3. Martin, E.L. and R.A. MacLeod, Isolation and chemical composition of the 
cytoplasmic membrane of a gram-negative bacterium. J Bacteriol, 1971. 105(3): 
p. 1160-7. 
4. Vollmer, W., D. Blanot, and M.A. de Pedro, Peptidoglycan structure and 
architecture. FEMS Microbiol Rev, 2008. 32(2): p. 149-67. 
5. Haggerty, E., Characterization of a potential undecaprenyl phosphate binding site 
on the Escherichia coli O-antigen initiation enzyme, WecA, in Microbiology and 
Immunology. 2008, The University of Western Ontario: London, ON, Canada. 
6. Kuhn, H.M., U. Meier-Dieter, and H. Mayer, ECA, the enterobacterial common 
antigen. FEMS Microbiol Rev, 1988. 4(3): p. 195-222. 
7. Makela, P.H. and H. Mayer, Enterobacterial common antigen. Bacteriol Rev, 
1976. 40(3): p. 591-632. 
8. Mannel, D. and H. Mayer, Isolation and chemical characterization of the 
enterobacterial common antigen. Eur J Biochem, 1978. 86(2): p. 361-70. 
  84 
 
9. Whitfield, C., Biosynthesis and assembly of capsular polysaccharides in 
Escherichia coli. Annu Rev Biochem, 2006. 75: p. 39-68. 
10. Whitfield, C. and I.S. Roberts, Structure, assembly and regulation of expression 
of capsules in Escherichia coli. Mol Microbiol, 1999. 31(5): p. 1307-19. 
11. Hornef, M.W., et al., Bacterial strategies for overcoming host innate and adaptive 
immune responses. Nat Immunol, 2002. 3(11): p. 1033-40. 
12. Joiner, K.A., Complement evasion by bacteria and parasites. Annu Rev 
Microbiol, 1988. 42: p. 201-30. 
13. Raetz, C.R. and C. Whitfield, Lipopolysaccharide endotoxins. Annu Rev 
Biochem, 2002. 71: p. 635-700. 
14. Holst, O., et al., Biochemistry and cell biology of bacterial endotoxins. FEMS 
Immunol Med Microbiol, 1996. 16(2): p. 83-104. 
15. Orskov, I., et al., Serology, chemistry, and genetics of O and K antigens of 
Escherichia coli. Bacteriol Rev, 1977. 41(3): p. 667-710. 
16. Samuel, G. and P. Reeves, Biosynthesis of O-antigens: genes and pathways 
involved in nucleotide sugar precursor synthesis and O-antigen assembly. 
Carbohydr Res, 2003. 338(23): p. 2503-19. 
17. Valvano, M.A., S. E. Furlong and K. B. Patel, Genetics, Biosynthesis and 
Assembly of O-antigen, in Bacterial Lipopolysaccharides, Y.A.a.M.A.V. Knirel, 
Editor. 2011, Springer/Wien: New York. p. 275-310. 
  85 
 
18. Al-Dabbagh, B., D. Mengin-Lecreulx, and A. Bouhss, Purification and 
characterization of the bacterial UDP-GlcNAc:undecaprenyl-phosphate GlcNAc-
1-phosphate transferase WecA. J Bacteriol, 2008. 190(21): p. 7141-6. 
19. Hug, I. and M.F. Feldman, Analogies and homologies in lipopolysaccharide and 
glycoprotein biosynthesis in bacteria. Glycobiology. 21(2): p. 138-51. 
20. Lehrer, J., et al., Functional characterization and membrane topology of 
Escherichia coli WecA, a sugar-phosphate transferase initiating the biosynthesis 
of enterobacterial common antigen and O-antigen lipopolysaccharide. J 
Bacteriol, 2007. 189(7): p. 2618-28. 
21. Valvano, M.A., Common themes in glycoconjugate assembly using the biogenesis 
of O-antigen lipopolysaccharide as a model system. Biochemistry (Mosc). 76(7): 
p. 729-35. 
22. Amer, A.O. and M.A. Valvano, Conserved amino acid residues found in a 
predicted cytosolic domain of the lipopolysaccharide biosynthetic protein WecA 
are implicated in the recognition of UDP-N-acetylglucosamine. Microbiology, 
2001. 147(Pt 11): p. 3015-25. 
23. Amer, A.O. and M.A. Valvano, Conserved aspartic acids are essential for the 
enzymic activity of the WecA protein initiating the biosynthesis of O-specific 
lipopolysaccharide and enterobacterial common antigen in Escherichia coli. 
Microbiology, 2002. 148(Pt 2): p. 571-82. 
  86 
 
24. Batchelor, R.A., et al., Regulation by a novel protein of the bimodal distribution 
of lipopolysaccharide in the outer membrane of Escherichia coli. J Bacteriol, 
1991. 173(18): p. 5699-704. 
25. Feldman, M.F., et al., The activity of a putative polyisoprenol-linked sugar 
translocase (Wzx) involved in Escherichia coli O antigen assembly is independent 
of the chemical structure of the O repeat. J Biol Chem, 1999. 274(49): p. 35129-
38. 
26. Klena, J.D., R.S. Ashford, 2nd, and C.A. Schnaitman, Role of Escherichia coli K-
12 rfa genes and the rfp gene of Shigella dysenteriae 1 in generation of 
lipopolysaccharide core heterogeneity and attachment of O antigen. J Bacteriol, 
1992. 174(22): p. 7297-307. 
27. Klena, J.D. and C.A. Schnaitman, Function of the rfb gene cluster and the rfe 
gene in the synthesis of O antigen by Shigella dysenteriae 1. Mol Microbiol, 1993. 
9(2): p. 393-402. 
28. Liu, D., R.A. Cole, and P.R. Reeves, An O-antigen processing function for Wzx 
(RfbX): a promising candidate for O-unit flippase. J Bacteriol, 1996. 178(7): p. 
2102-7. 
29. Macpherson, D.F., P.A. Manning, and R. Morona, Genetic analysis of the rfbX 
gene of Shigella flexneri. Gene, 1995. 155(1): p. 9-17. 
  87 
 
30. Marolda, C.L., et al., Functional analysis of predicted coiled-coil regions in the 
Escherichia coli K-12 O-antigen polysaccharide chain length determinant Wzz. J 
Bacteriol, 2008. 190(6): p. 2128-37. 
31. Marolda, C.L., J. Vicarioli, and M.A. Valvano, Wzx proteins involved in 
biosynthesis of O antigen function in association with the first sugar of the O-
specific lipopolysaccharide subunit. Microbiology, 2004. 150(Pt 12): p. 4095-
105. 
32. Morona, R., L. Van Den Bosch, and C. Daniels, Evaluation of Wzz/MPA1/MPA2 
proteins based on the presence of coiled-coil regions. Microbiology, 2000. 146 ( 
Pt 1): p. 1-4. 
33. Schnaitman, C.A. and J.D. Klena, Genetics of lipopolysaccharide biosynthesis in 
enteric bacteria. Microbiol Rev, 1993. 57(3): p. 655-82. 
34. Tocilj, A., et al., Bacterial polysaccharide co-polymerases share a common 
framework for control of polymer length. Nat Struct Mol Biol, 2008. 15(2): p. 
130-8. 
35. Whitfield, C., P.A. Amor, and R. Koplin, Modulation of the surface architecture 
of gram-negative bacteria by the action of surface polymer:lipid A-core ligase 
and by determinants of polymer chain length. Mol Microbiol, 1997. 23(4): p. 629-
38. 
36. Valvano, M.A., Export of O-specific lipopolysaccharide. Front Biosci, 2003. 8: p. 
s452-71. 
  88 
 
37. Reizer, J., A. Reizer, and M.H. Saier, Jr., A new subfamily of bacterial ABC-type 
transport systems catalyzing export of drugs and carbohydrates. Protein Sci, 
1992. 1(10): p. 1326-32. 
38. Jiang, X.M., et al., Structure and sequence of the rfb (O antigen) gene cluster of 
Salmonella serovar typhimurium (strain LT2). Mol Microbiol, 1991. 5(3): p. 695-
713. 
39. Patel, K.B., S.E. Furlong, and M.A. Valvano, Functional analysis of the C-
terminal domain of the WbaP protein that mediates initiation of O antigen 
synthesis in Salmonella enterica. Glycobiology. 20(11): p. 1389-401. 
40. Saldias, M.S., et al., Distinct functional domains of the Salmonella enterica WbaP 
transferase that is involved in the initiation reaction for synthesis of the O antigen 
subunit. Microbiology, 2008. 154(Pt 2): p. 440-53. 
41. Wang, L., D. Liu, and P.R. Reeves, C-terminal half of Salmonella enterica WbaP 
(RfbP) is the galactosyl-1-phosphate transferase domain catalyzing the first step 
of O-antigen synthesis. J Bacteriol, 1996. 178(9): p. 2598-604. 
42. Patel, K.B., et al., The C-terminal domain of the Salmonella enterica WbaP 
(UDP-galactose:Und-P galactose-1-phosphate transferase) is sufficient for 
catalytic activity and specificity for undecaprenyl monophosphate. Glycobiology. 
22(1): p. 116-22. 
  89 
 
43. Stevenson, G., et al., Organization of the Escherichia coli K-12 gene cluster 
responsible for production of the extracellular polysaccharide colanic acid. J 
Bacteriol, 1996. 178(16): p. 4885-93. 
44. Drummelsmith, J. and C. Whitfield, Gene products required for surface 
expression of the capsular form of the group 1 K antigen in Escherichia coli 
(O9a:K30). Mol Microbiol, 1999. 31(5): p. 1321-32. 
45. Patel, K.B., et al., Functional characterization of UDP-glucose:undecaprenyl-
phosphate glucose-1-phosphate transferases of Escherichia coli and Caulobacter 
crescentus. J Bacteriol. 194(10): p. 2646-57. 
46. Cartee, R.T., et al., CpsE from type 2 Streptococcus pneumoniae catalyzes the 
reversible addition of glucose-1-phosphate to a polyprenyl phosphate acceptor, 
initiating type 2 capsule repeat unit formation. J Bacteriol, 2005. 187(21): p. 
7425-33. 
47. Xayarath, B. and J. Yother, Mutations blocking side chain assembly, 
polymerization, or transport of a Wzy-dependent Streptococcus pneumoniae 
capsule are lethal in the absence of suppressor mutations and can affect polymer 
transfer to the cell wall. J Bacteriol, 2007. 189(9): p. 3369-81. 
48. Steiner, K., et al., Functional characterization of the initiation enzyme of S-layer 
glycoprotein glycan biosynthesis in Geobacillus stearothermophilus NRS 
2004/3a. J Bacteriol, 2007. 189(7): p. 2590-8. 
  90 
 
49. Rush, J.S., P.D. Rick, and C.J. Waechter, Polyisoprenyl phosphate specificity of 
UDP-GlcNAc:undecaprenyl phosphate N-acetylglucosaminyl 1-P transferase 
from E.coli. Glycobiology, 1997. 7(2): p. 315-22. 
50. Price, N.P. and F.A. Momany, Modeling bacterial UDP-HexNAc: polyprenol-P 
HexNAc-1-P transferases. Glycobiology, 2005. 15(9): p. 29R-42R. 
51. Furlong, S.E. and M.A. Valvano, Characterization of the highly conserved 
VFMGD motif in a bacterial polyisoprenyl-phosphate N-acetylaminosugar-1-
phosphate transferase. Protein Sci. 21(9): p. 1366-75. 
52. Hubbard, S.C. and R.J. Ivatt, Synthesis and processing of asparagine-linked 
oligosaccharides. Annu Rev Biochem, 1981. 50: p. 555-83. 
53. Lehrman, M.A., A family of UDP-GlcNAc/MurNAc: polyisoprenol-P 
GlcNAc/MurNAc-1-P transferases. Glycobiology, 1994. 4(6): p. 768-71. 
54. Clarke, B.R., et al., Role of Rfe and RfbF in the initiation of biosynthesis of D-
galactan I, the lipopolysaccharide O antigen from Klebsiella pneumoniae 
serotype O1. J Bacteriol, 1995. 177(19): p. 5411-8. 
55. Yao, Z. and M.A. Valvano, Genetic analysis of the O-specific lipopolysaccharide 
biosynthesis region (rfb) of Escherichia coli K-12 W3110: identification of genes 
that confer group 6 specificity to Shigella flexneri serotypes Y and 4a. J Bacteriol, 
1994. 176(13): p. 4133-43. 
  91 
 
56. Zhang, L., et al., Molecular and chemical characterization of the 
lipopolysaccharide O-antigen and its role in the virulence of Yersinia 
enterocolitica serotype O:8. Mol Microbiol, 1997. 23(1): p. 63-76. 
57. Alexander, D.C. and M.A. Valvano, Role of the rfe gene in the biosynthesis of the 
Escherichia coli O7-specific lipopolysaccharide and other O-specific 
polysaccharides containing N-acetylglucosamine. J Bacteriol, 1994. 176(22): p. 
7079-84. 
58. Schmidt, G., H. Mayer, and P.H. Makela, Presence of rfe genes in Escherichia 
coli: their participation in biosynthesis of O antigen and enterobacterial common 
antigen. J Bacteriol, 1976. 127(2): p. 755-62. 
59. Amor, P.A. and C. Whitfield, Molecular and functional analysis of genes 
required for expression of group IB K antigens in Escherichia coli: 
characterization of the his-region containing gene clusters for multiple cell-
surface polysaccharides. Mol Microbiol, 1997. 26(1): p. 145-61. 
60. Belanger, M., L.L. Burrows, and J.S. Lam, Functional analysis of genes 
responsible for the synthesis of the B-band O antigen of Pseudomonas aeruginosa 
serotype O6 lipopolysaccharide. Microbiology, 1999. 145 ( Pt 12): p. 3505-21. 
61. Ikeda, M., et al., The Escherichia coli mraY gene encoding UDP-N-
acetylmuramoyl-pentapeptide: undecaprenyl-phosphate phospho-N-
acetylmuramoyl-pentapeptide transferase. J Bacteriol, 1991. 173(3): p. 1021-6. 
  92 
 
62. Rocchetta, H.L., et al., Three rhamnosyltransferases responsible for assembly of 
the A-band D-rhamnan polysaccharide in Pseudomonas aeruginosa: a fourth 
transferase, WbpL, is required for the initiation of both A-band and B-band 
lipopolysaccharide synthesis. Mol Microbiol, 1998. 28(6): p. 1103-19. 
63. Bugg, T.D. and P.E. Brandish, From peptidoglycan to glycoproteins: common 
features of lipid-linked oligosaccharide biosynthesis. FEMS Microbiol Lett, 1994. 
119(3): p. 255-62. 
64. Dal Nogare, A.R., N. Dan, and M.A. Lehrman, Conserved sequences in enzymes 
of the UDP-GlcNAc/MurNAc family are essential in hamster UDP-
GlcNAc:dolichol-P GlcNAc-1-P transferase. Glycobiology, 1998. 8(6): p. 625-32. 
65. Anderson, M.S., S.S. Eveland, and N.P. Price, Conserved cytoplasmic motifs that 
distinguish sub-groups of the polyprenol phosphate:N-acetylhexosamine-1-
phosphate transferase family. FEMS Microbiol Lett, 2000. 191(2): p. 169-75. 
66. Zhu, X.Y. and M.A. Lehrman, Cloning, sequence, and expression of a cDNA 
encoding hamster UDP-GlcNAc:dolichol phosphate N-acetylglucosamine-1-
phosphate transferase. J Biol Chem, 1990. 265(24): p. 14250-5. 
67. Bouhss, A., et al., Topological analysis of the MraY protein catalysing the first 
membrane step of peptidoglycan synthesis. Mol Microbiol, 1999. 34(3): p. 576-
85. 
68. Eddy, S.R., Hidden Markov models. Curr Opin Struct Biol, 1996. 6(3): p. 361-5. 
  93 
 
69. Amer, A.O. and M.A. Valvano, The N-terminal region of the Escherichia coli 
WecA (Rfe) protein, containing three predicted transmembrane helices, is 
required for function but not for membrane insertion. J Bacteriol, 2000. 182(2): p. 
498-503. 
70. Sekine, S., et al., Crucial role of the high-loop lysine for the catalytic activity of 
arginyl-tRNA synthetase. J Biol Chem, 2001. 276(6): p. 3723-6. 
71. Venkatachalam, K.V., et al., Site-selected mutagenesis of a conserved nucleotide 
binding HXGH motif located in the ATP sulfurylase domain of human 
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase. J Biol Chem, 1999. 
274(5): p. 2601-4. 
72. Lloyd, A.J., et al., Phospho-N-acetyl-muramyl-pentapeptide translocase from 
Escherichia coli: catalytic role of conserved aspartic acid residues. J Bacteriol, 
2004. 186(6): p. 1747-57. 
73. Liang, J., et al., Computational studies of membrane proteins: models and 
predictions for biological understanding. Biochim Biophys Acta. 1818(4): p. 927-
41. 
74. Kyte, J. and R.F. Doolittle, A simple method for displaying the hydropathic 
character of a protein. J Mol Biol, 1982. 157(1): p. 105-32. 
75. Cymer, F., A. Veerappan, and D. Schneider, Transmembrane helix-helix 
interactions are modulated by the sequence context and by lipid bilayer 
properties. Biochim Biophys Acta. 1818(4): p. 963-73. 
  94 
 
76. Simon, I., A. Fiser, and G.E. Tusnady, Predicting protein conformation by 
statistical methods. Biochim Biophys Acta, 2001. 1549(2): p. 123-36. 
77. Ehrmann, M., D. Boyd, and J. Beckwith, Genetic analysis of membrane protein 
topology by a sandwich gene fusion approach. Proc Natl Acad Sci U S A, 1990. 
87(19): p. 7574-8. 
78. Haardt, M. and E. Bremer, Use of phoA and lacZ fusions to study the membrane 
topology of ProW, a component of the osmoregulated ProU transport system of 
Escherichia coli. J Bacteriol, 1996. 178(18): p. 5370-81. 
79. Manoil, C., Analysis of protein localization by use of gene fusions with 
complementary properties. J Bacteriol, 1990. 172(2): p. 1035-42. 
80. Silhavy, T.J. and J.R. Beckwith, Uses of lac fusions for the study of biological 
problems. Microbiol Rev, 1985. 49(4): p. 398-418. 
81. Bogdanov, M., P.N. Heacock, and W. Dowhan, A polytopic membrane protein 
displays a reversible topology dependent on membrane lipid composition. Embo 
J, 2002. 21(9): p. 2107-16. 
82. Bogdanov, M., et al., Transmembrane protein topology mapping by the 
substituted cysteine accessibility method (SCAM(TM)): application to lipid-
specific membrane protein topogenesis. Methods, 2005. 36(2): p. 148-71. 
  95 
 
83. Cao, W. and L.H. Matherly, Analysis of the membrane topology for 
transmembrane domains 7-12 of the human reduced folate carrier by scanning 
cysteine accessibility methods. Biochem J, 2004. 378(Pt 1): p. 201-6. 
84. Grunewald, M., D. Menaker, and B.I. Kanner, Cysteine-scanning mutagenesis 
reveals a conformationally sensitive reentrant pore-loop in the glutamate 
transporter GLT-1. J Biol Chem, 2002. 277(29): p. 26074-80. 
85. Loo, T.W. and D.M. Clarke, Membrane topology of a cysteine-less mutant of 
human P-glycoprotein. J Biol Chem, 1995. 270(2): p. 843-8. 
86. Sato, Y., et al., Analysis of transmembrane domain 2 of rat serotonin transporter 
by cysteine scanning mutagenesis. J Biol Chem, 2004. 279(22): p. 22926-33. 
87. Wang, X., M. Bogdanov, and W. Dowhan, Topology of polytopic membrane 
protein subdomains is dictated by membrane phospholipid composition. Embo J, 
2002. 21(21): p. 5673-81. 
88. Culham, D.E., et al., Creation of a fully functional cysteine-less variant of 
osmosensor and proton-osmoprotectant symporter ProP from Escherichia coli 
and its application to assess the transporter's membrane orientation. 
Biochemistry, 2003. 42(40): p. 11815-23. 
89. Lu, J. and C. Deutsch, Pegylation: a method for assessing topological 
accessibilities in Kv1.3. Biochemistry, 2001. 40(44): p. 13288-301. 
  96 
 
90. Falke, J.J., et al., Structure of a bacterial sensory receptor. A site-directed 
sulfhydryl study. J Biol Chem, 1988. 263(29): p. 14850-8. 
91. Kumarevel, T.S., M.M. Gromiha, and M.N. Ponnuswamy, Distribution of amino 
acid residues and residue-residue contacts in molecular chaperones. Prep 
Biochem Biotechnol, 2001. 31(2): p. 163-83. 
92. Lehrer, J., Topological mapping of the Escherichia coli WecA protein by site-
directed sulfhydryl labeling, in Microbiology and Immunology. 2005, The 
University of Western Ontario: London, ON, Canada. 
93. Koch, S., et al., Escherichia coli TatA and TatB proteins have N-out, C-in 
topology in intact cells. J Biol Chem. 287(18): p. 14420-31. 
94. Leive, L., Studies on the permeability change produced in coliform bacteria by 
ethylenediaminetetraacetate. J Biol Chem, 1968. 243(9): p. 2373-80. 
95. Bauer, J., et al., Topology and accessibility of the transmembrane helices and the 
sensory site in the bifunctional transporter DcuB of Escherichia coli. 
Biochemistry. 50(26): p. 5925-38. 
96. Guzman, L.M., et al., Tight regulation, modulation, and high-level expression by 
vectors containing the arabinose PBAD promoter. J Bacteriol, 1995. 177(14): p. 
4121-30. 
  97 
 
97. Sambrook, J., E.F. Fritsch, and T. Maniatis, Molecular cloning : a laboratory 
manual. 2nd ed. 1989, Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory 
Press. 
98. Laemmli, U.K., Cleavage of structural proteins during the assembly of the head 
of bacteriophage T4. Nature, 1970. 227(5259): p. 680-5. 
99. Hitchcock, P.J. and T.M. Brown, Morphological heterogeneity among Salmonella 
lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol, 
1983. 154(1): p. 269-77. 
100. Marolda, C.L., et al., Genetic analysis of the O7-polysaccharide biosynthesis 
region from the Escherichia coli O7:K1 strain VW187. J Bacteriol, 1990. 172(7): 
p. 3590-9. 
101. Tsai, C.M. and C.E. Frasch, A sensitive silver stain for detecting 
lipopolysaccharides in polyacrylamide gels. Anal Biochem, 1982. 119(1): p. 115-
9. 
102. Troy, F.A., 2nd, Polysialylation: from bacteria to brains. Glycobiology, 1992. 
2(1): p. 5-23. 
103. Toei, M., S. Toei, and M. Forgac, Definition of membrane topology and 
identification of residues important for transport in subunit a of the vacuolar 
ATPase. J Biol Chem. 286(40): p. 35176-86. 
  98 
 
104. Wang, Y., M. Toei, and M. Forgac, Analysis of the membrane topology of 
transmembrane segments in the C-terminal hydrophobic domain of the yeast 
vacuolar ATPase subunit a (Vph1p) by chemical modification. J Biol Chem, 2008. 
283(30): p. 20696-702. 
105. Zhou, G.P. and F.A. Troy, 2nd, Characterization by NMR and molecular 
modeling of the binding of polyisoprenols and polyisoprenyl recognition sequence 
peptides: 3D structure of the complexes reveals sites of specific interactions. 
Glycobiology, 2003. 13(2): p. 51-71. 
106. Zhou, G.P. and F.A. Troy, 2nd, NMR study of the preferred membrane orientation 
of polyisoprenols (dolichol) and the impact of their complex with polyisoprenyl 
recognition sequence peptides on membrane structure. Glycobiology, 2005. 
15(4): p. 347-59. 
107. Roy, A., A. Kucukural, and Y. Zhang, I-TASSER: a unified platform for 
automated protein structure and function prediction. Nat Protoc. 5(4): p. 725-38. 
108. Zhang, Y., I-TASSER server for protein 3D structure prediction. BMC 
Bioinformatics, 2008. 9: p. 40. 
 
 
 
 
 
 
  99 
 
 
 
 
 
 
 
 
 
 
 
Appendices 
 
 
 
 
 
 
 
 
 
 
 
 
  100 
 
Appendix A 
 
 
 
Ab initio 3D model of WecA.  The 3D model was derived using the I-TASSER server. A) View from the 
side. B) View through the bilayer. C) View from the periplasm. D) Tilted view from the side. The residues 
located along TMs IV and V that label in membrane preparations (suggesting exposure to the cytosol) are 
highlighted in orange. The residues located along TMs IV and V that do not label in membrane 
preparations (suggesting they are facing into the bilayer) are highlighted in blue. The residues S120, L122, 
and Y124 located along TMs IV and V that label in EDTA-permeabilized cells (suggesting exposure to the 
periplasm) are highlighted in red. Other critical aspartic acids D35, D90, D91, D156, and D159 are 
highlighted in yellow while H278 is highlighted in magenta and A286 is highlighted in pale blue. 
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